Sector Alpha Week of 2026-07-28
20-quarter listed-company comparison

Health Information Services Stocks

Health Information Services: BrightSpring Health Services, Inc. owns the largest revenue base; Carlsmed, Inc. has the fastest current growth.

The industry itself · before any single company

How has Health Information Services moved against S&P 500?

The line below covers 5.2 years. Over the most recent two of them this industry is 14% ahead of S&P 500. Earnings across its companies grew 11% on average over the last four reported quarters. It has been ahead of S&P 500 on a rolling three-month view for 13 weeks running.

FADING · −2 in 4w~Moving with the index17 of 28 companies ahead of S&P 500 by 5% or more over three months1 is 20% or more behind over a year while earnings grew 20% or more

RS ↑13w · 18/28 >200d (−1) · 17/28 lead (−2) · EPS 17/28↑

100200202620252024202320222021 179348 TRAILING 12-MONTH EPS · 100 AT THE START0100101Mar 22Sep 22Mar 23Sep 23Mar 24Sep 24Mar 25Sep 25Mar 26Mar 2022 · trailing 12-month earnings per share at 100, against 100 at the start · no comparable year yet · 7 reportingJun 2022 · trailing 12-month earnings per share at 101, against 100 at the start · no comparable year yet · 8 reportingSep 2022 · trailing 12-month earnings per share at 95, against 100 at the start · no comparable year yet · 8 reportingDec 2022 · trailing 12-month earnings per share at 84, against 100 at the start · no comparable year yet · 8 reportingMar 2023 · trailing 12-month earnings per share at 79, against 100 at the start · down 38.1% on a year ago · 8 reportingJun 2023 · trailing 12-month earnings per share at 80, against 100 at the start · down 21.4% on a year ago · 8 reportingSep 2023 · trailing 12-month earnings per share at 82, against 100 at the start · down 19.7% on a year ago · 8 reportingDec 2023 · trailing 12-month earnings per share at 90, against 100 at the start · down 1.6% on a year ago · 8 reportingMar 2024 · trailing 12-month earnings per share at 90, against 100 at the start · up 3.2% on a year ago · 8 reportingJun 2024 · trailing 12-month earnings per share at 85, against 100 at the start · down 55.6% on a year ago · 8 reportingSep 2024 · trailing 12-month earnings per share at 83, against 100 at the start · down 1.3% on a year ago · 8 reportingDec 2024 · trailing 12-month earnings per share at 72, against 100 at the start · down 3.9% on a year ago · 8 reportingMar 2025 · trailing 12-month earnings per share at 67, against 100 at the start · up 1.3% on a year ago · 8 reportingJun 2025 · trailing 12-month earnings per share at 43, against 100 at the start · up 10.7% on a year ago · 8 reportingSep 2025 · trailing 12-month earnings per share at 72, against 100 at the start · up 19.7% on a year ago · 8 reportingDec 2025 · trailing 12-month earnings per share at 95, against 100 at the start · up 20.0% on a year ago · 8 reportingMar 2026 · trailing 12-month earnings per share at 87, against 100 at the start · down 7.6% on a year ago · 8 reportingNot reported yet — earnings trail price by a quarter or two87 · Mar 26No earnings on file this far back — the price series reaches further than the filings do
100200202620252024202320222021 179348 TRAILING 12-MONTH EPS · 100 AT THE START0100101Mar 22Mar 23Mar 24Mar 25Mar 26Mar 2022 · trailing 12-month earnings per share at 100, against 100 at the start · no comparable year yet · 7 reportingJun 2022 · trailing 12-month earnings per share at 101, against 100 at the start · no comparable year yet · 8 reportingSep 2022 · trailing 12-month earnings per share at 95, against 100 at the start · no comparable year yet · 8 reportingDec 2022 · trailing 12-month earnings per share at 84, against 100 at the start · no comparable year yet · 8 reportingMar 2023 · trailing 12-month earnings per share at 79, against 100 at the start · down 38.1% on a year ago · 8 reportingJun 2023 · trailing 12-month earnings per share at 80, against 100 at the start · down 21.4% on a year ago · 8 reportingSep 2023 · trailing 12-month earnings per share at 82, against 100 at the start · down 19.7% on a year ago · 8 reportingDec 2023 · trailing 12-month earnings per share at 90, against 100 at the start · down 1.6% on a year ago · 8 reportingMar 2024 · trailing 12-month earnings per share at 90, against 100 at the start · up 3.2% on a year ago · 8 reportingJun 2024 · trailing 12-month earnings per share at 85, against 100 at the start · down 55.6% on a year ago · 8 reportingSep 2024 · trailing 12-month earnings per share at 83, against 100 at the start · down 1.3% on a year ago · 8 reportingDec 2024 · trailing 12-month earnings per share at 72, against 100 at the start · down 3.9% on a year ago · 8 reportingMar 2025 · trailing 12-month earnings per share at 67, against 100 at the start · up 1.3% on a year ago · 8 reportingJun 2025 · trailing 12-month earnings per share at 43, against 100 at the start · up 10.7% on a year ago · 8 reportingSep 2025 · trailing 12-month earnings per share at 72, against 100 at the start · up 19.7% on a year ago · 8 reportingDec 2025 · trailing 12-month earnings per share at 95, against 100 at the start · up 20.0% on a year ago · 8 reportingMar 2026 · trailing 12-month earnings per share at 87, against 100 at the start · down 7.6% on a year ago · 8 reportingNot reported yet — earnings trail price by a quarter or two87No earnings on file this far back — the price series reaches further than the filings do
Health Information Services, equal-weighted, based at 200 S&P 500, same base, same start trailing 12-month earnings per share rising falling
Strength anatomy MixedHow much of the industry is participating, how recently, and whether the movers score well.
Together17 of 28 stocks moving
Fresh4 crossed in the last 4 weeks
Backed by scoresmovers score +4 vs the industry average
Down the cap ladder — bar is now, tick is four weeks ago
Large 5/6+1
Mid 6/10−1
Small 6/12−2

Participation is not spreading downward this month; the larger companies are still carrying most of it.

Both lines start at 200 in the same week, so the distance between them is the whole story: the industry line is an equal-weighted index of its 28 companies. The bars underneath are trailing 12-month earnings per share, one bar per reported quarter, each member rebased to 100 at the start and the industry taking the median — so a price line pulling away from flat bars is a re-rating, not earnings. A bar turns red when that figure is lower than the quarter before. Rules are fixed and applied identically everywhere on this site: ahead by 5% or more over three months, or behind by 20% or more over a year while earnings grew 20% or more. Hover any point to read both values and the gap. This is a description of what the numbers did, not advice.

Sector relative strength · before individual stocks

Is Health Information Services outperforming S&P 500?

Health Information Services has underperformed S&P 500 by 4.4% over the last 52 weeks. Over 13 weeks the gap is a lead of 13.7%. 14 of 28 covered companies currently beat the S&P 500 on Mansfield relative strength, so leadership inside the sector is selective. 10x Genomics, Inc. is the strongest against the sector itself at +94.9%.

+13.7%Sector vs S&P 500 · 13 weeks
-4.4%Sector vs S&P 500 · 52 weeks
14/28Stocks leading S&P 500
12/28Stocks leading sector

Sector metric: — as of latest available · unclassified · direction unavailable.

The central tension: the companies with the most scale are not necessarily the companies creating the most change.

Start with scale. Then earnings trajectory. Then business quality. Only after those three agree should price leadership carry much weight.

Bottom line

Health Information Services has underperformed S&P 500 by 4.4% over 52 weeks and 13.7% over 13 weeks. 14 of 28 covered companies beat the S&P 500 on Mansfield relative strength, while 12 of 28 beat the sector itself. BrightSpring Health Services, Inc. leads with revenue of $13,647 million, based on 28 of 29 comparable companies through Mar 2026.

Is the Health Information Services sector outperforming S&P 500?

Health Information Services has underperformed S&P 500 by 4.4% over 52 weeks and 13.7% over 13 weeks. 14 of 28 covered companies beat the S&P 500 on Mansfield relative strength, while 12 of 28 beat the sector itself.

Which Health Information Services company is largest by revenue?

BrightSpring Health Services, Inc. leads with revenue of $13,647 million, based on 28 of 29 comparable companies through Mar 2026.

Which Health Information Services company is growing fastest?

Carlsmed, Inc. has the fastest current revenue growth at 75%, across 28 of 29 comparable companies.

Which Health Information Services company has the strongest 4-Factor Sector Score?

Simulations Plus, Inc. ranks first at 65.9/100 with 52.7% evidence confidence. The score prioritizes research; it is not a buy recommendation.

Which Health Information Services company reports the most CAPEX?

Claritev Corporation reports the largest latest CAPEX at $47 million, with 28 of 29 companies comparable.

Which Health Information Services company has the least gross debt?

Omada Health, Inc. has the lowest comparable gross debt at $0 million. BrightSpring Health Services, Inc. has the highest at $2,700 million.

Which Health Information Services company has the lowest comparable PEG?

Veeva Systems Inc. has the lowest comparable Guarded PEG at 1.47, among 6 of 29 companies that pass the metric’s comparability rules.

How much history does this Health Information Services comparison include?

The page compares up to 20 reported quarters per company for fundamentals, CAPEX, debt and valuation, ending Jun 2026. Missing observations remain blank rather than being estimated.

How is the 4-Factor Sector Score calculated?

The four visible contributions add directly: growth and earnings up to 35 points, capital efficiency up to 25, valuation up to 20, and relative strength up to 20. Missing or stale evidence moves only the affected contribution toward neutral.

Companies
29
complete canonical membership
Combined market value
$104.0B
Veeva Systems Inc.
Revenue growing
22/28
positive TTM year-on-year growth
Beating S&P 500
14/28
positive Mansfield relative strength
Global company selection
00 · research priority, made explicit

4-Factor Sector Score

An additive sector-relative research score. The four displayed point contributions always equal the total: Growth & earnings (35), Capital efficiency (25), Valuation (20), and Relative strength (20). Missing or stale evidence is absorbed inside the affected factor, never applied as a hidden adjustment.

Growth & earnings · 35%Capital efficiency · 25%Valuation · 20%Relative strength · 20%
Simulations Plus, Inc. has the strongest current balance of earnings trajectory, business quality, valuation and price confirmation, with 52.7% evidence confidence.
Teladoc Health, Inc. has stronger price confirmation than earnings confirmation; that is a research prompt, not permission to chase.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is guarded: positive earnings, positive 5–60% three-year EPS growth, and a positive P/E are required.

1. Simulations Plus, Inc. · SLP

65.9/100 · Thin evidence · provisional · 53% evidence

Exact sum: 24.6 + 17.8 + 10.1 + 13.4 = 65.9

Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

24.6/35Growth & earnings

Revenue — · PAT — · OPM change 11.1 pp

45% evidence

17.8/25Capital efficiency

ROCE 3.4% · debt/equity 0×

80% evidence

10.1/20Valuation

P/E 42.8× · PEG —

15% evidence

13.4/20Relative strength

RS sector 3.2% · RS bench 7.4% · 1Y 43.2%

70% evidence

2. HealthEquity, Inc. · HQY

63.0/100 · Mixed-positive evidence · 86% evidence

Exact sum: 22.7 + 14.4 + 12.6 + 13.3 = 63

Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

22.7/35Growth & earnings

Revenue 7.6% · PAT 89.3% · OPM change 3.9 pp

95% evidence

14.4/25Capital efficiency

ROCE 3.2% · debt/equity 0.48×

80% evidence

12.6/20Valuation

P/E 30.7× · PEG 1.57

65% evidence

13.3/20Relative strength

RS sector 1.2% · RS bench 5.5% · 1Y 11.2%

100% evidence

3. Hinge Health, Inc. · HNGE

62.4/100 · Mixed-positive evidence · 63% evidence

Exact sum: 19.6 + 16.5 + 10 + 16.3 = 62.4

Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

19.6/35Growth & earnings

Revenue 49.5% · PAT -1748.4% · OPM change 7 pp

83% evidence

16.5/25Capital efficiency

ROCE 8.4% · debt/equity 0.02×

80% evidence

10.0/20Valuation

P/E — · PEG —

0% evidence

16.3/20Relative strength

RS sector 29.4% · RS bench 34.4% · 1Y 67.4%

70% evidence

4. Veeva Systems Inc. · VEEV

60.0/100 · Mixed-positive evidence · 86% evidence

Exact sum: 20.2 + 18.4 + 13.8 + 7.6 = 60

Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

20.2/35Growth & earnings

Revenue 16.3% · PAT 20.5% · OPM change 0.1 pp

95% evidence

18.4/25Capital efficiency

ROCE 4% · debt/equity 0.01×

80% evidence

13.8/20Valuation

P/E 27.8× · PEG 1.47

65% evidence

7.6/20Relative strength

RS sector -17.1% · RS bench -14.8% · 1Y -28.5%

100% evidence

5. 10x Genomics, Inc. · TXG

59.7/100 · Mixed-positive evidence · 62% evidence

Exact sum: 20.1 + 9.6 + 10 + 20 = 59.7

Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

20.1/35Growth & earnings

Revenue 2.2% · PAT — · OPM change 14.1 pp

62% evidence

9.6/25Capital efficiency

ROCE -2% · debt/equity 0.1×

80% evidence

10.0/20Valuation

P/E — · PEG —

0% evidence

20.0/20Relative strength

RS sector 94.9% · RS bench 106.6% · 1Y 259.7%

100% evidence

6. Omada Health, Inc. · OMDA

59.1/100 · Thin evidence · provisional · 56% evidence

Exact sum: 25.2 + 10.9 + 10 + 13 = 59.1

Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

25.2/35Growth & earnings

Revenue 49% · PAT — · OPM change 9.2 pp

62% evidence

10.9/25Capital efficiency

ROCE -2.9% · debt/equity 0×

80% evidence

10.0/20Valuation

P/E — · PEG —

0% evidence

13.0/20Relative strength

RS sector 2.9% · RS bench 5.7% · 1Y 17.5%

70% evidence

7. HealthStream, Inc. · HSTM

57.7/100 · Mixed-positive evidence · 82% evidence

Exact sum: 18.8 + 15.7 + 5.8 + 17.4 = 57.7

Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

18.8/35Growth & earnings

Revenue 6.5% · PAT 5.3% · OPM change 3.3 pp

83% evidence

15.7/25Capital efficiency

ROCE 1.9% · debt/equity 0.04×

80% evidence

5.8/20Valuation

P/E 30.9× · PEG 4.87

65% evidence

17.4/20Relative strength

RS sector 5.8% · RS bench 9.9% · 1Y 12.5%

100% evidence

8. BrightSpring Health Services, Inc. · BTSG

57.5/100 · Mixed-positive evidence · 65% evidence

Exact sum: 21.3 + 10.7 + 10.4 + 15.1 = 57.5

Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

21.3/35Growth & earnings

Revenue 28% · PAT — · OPM change 1.6 pp

62% evidence

10.7/25Capital efficiency

ROCE 2.7% · debt/equity 1.36×

80% evidence

10.4/20Valuation

P/E 34.6× · PEG —

15% evidence

15.1/20Relative strength

RS sector 49.7% · RS bench 59.3% · 1Y 268.9%

100% evidence

9. Teladoc Health, Inc. · TDOC

52.2/100 · Thin evidence · provisional · 56% evidence

Exact sum: 16.8 + 9.4 + 10 + 16 = 52.2

Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

16.8/35Growth & earnings

Revenue -1.5% · PAT — · OPM change 9.1 pp

62% evidence

9.4/25Capital efficiency

ROCE -2.5% · debt/equity 0.06×

80% evidence

10.0/20Valuation

P/E — · PEG —

0% evidence

16.0/20Relative strength

RS sector 18.8% · RS bench 22.7% · 1Y 34.9%

70% evidence

10. Waystar Holding Corp. · WAY

51.4/100 · Mixed-positive evidence · 72% evidence

Exact sum: 21.7 + 12.9 + 10.3 + 6.5 = 51.4

Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

21.7/35Growth & earnings

Revenue 18.8% · PAT 100% · OPM change 0.2 pp

83% evidence

12.9/25Capital efficiency

ROCE 1.6% · debt/equity 0.38×

80% evidence

10.3/20Valuation

P/E 36× · PEG —

15% evidence

6.5/20Relative strength

RS sector -26.1% · RS bench -23.9% · 1Y -33.4%

100% evidence

11. Omnicell, Inc. · OMCL

50.9/100 · Mixed-positive evidence · 65% evidence

Exact sum: 21.1 + 12.7 + 9 + 8.1 = 50.9

Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

21.1/35Growth & earnings

Revenue 7.9% · PAT -9.1% · OPM change 9.7 pp

62% evidence

12.7/25Capital efficiency

ROCE 1.1% · debt/equity 0.15×

80% evidence

9.0/20Valuation

P/E 75.9× · PEG —

15% evidence

8.1/20Relative strength

RS sector -1.4% · RS bench 4% · 1Y 44.7%

100% evidence

12. Phreesia, Inc. · PHR

50.4/100 · Mixed-positive evidence · 68% evidence

Exact sum: 22.5 + 12 + 9.7 + 6.2 = 50.4

Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

22.5/35Growth & earnings

Revenue 13.8% · PAT 100% · OPM change 8 pp

71% evidence

12.0/25Capital efficiency

ROCE 1.7% · debt/equity 0.26×

80% evidence

9.7/20Valuation

P/E 61.4× · PEG —

15% evidence

6.2/20Relative strength

RS sector -38.6% · RS bench -37.9% · 1Y -58.8%

100% evidence

13. Weave Communications, Inc. · WEAV

48.2/100 · Thin evidence · provisional · 56% evidence

Exact sum: 21.4 + 7.1 + 10 + 9.7 = 48.2

Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

21.4/35Growth & earnings

Revenue 16.4% · PAT — · OPM change 7.5 pp

62% evidence

7.1/25Capital efficiency

ROCE -5.1% · debt/equity 0.61×

80% evidence

10.0/20Valuation

P/E — · PEG —

0% evidence

9.7/20Relative strength

RS sector -2.1% · RS bench 1.4% · 1Y 0.9%

70% evidence

14. Privia Health Group, Inc. · PRVA

46.4/100 · Mixed-negative evidence · 82% evidence

Exact sum: 22.2 + 13.7 + 4.7 + 5.8 = 46.4

Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

22.2/35Growth & earnings

Revenue 24.7% · PAT 40% · OPM change 0.1 pp

83% evidence

13.7/25Capital efficiency

ROCE 1% · debt/equity 0.01×

80% evidence

4.7/20Valuation

P/E 128.6× · PEG 3.86

65% evidence

5.8/20Relative strength

RS sector -5.9% · RS bench -1.5% · 1Y 31.7%

100% evidence

15. SOPHiA GENETICS SA · SOPH

46.0/100 · Thin evidence · provisional · 56% evidence

Exact sum: 17.4 + 4.2 + 10 + 14.4 = 46

Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

17.4/35Growth & earnings

Revenue 19.1% · PAT — · OPM change 10.5 pp

62% evidence

4.2/25Capital efficiency

ROCE -15.1% · debt/equity 1.35×

80% evidence

10.0/20Valuation

P/E — · PEG —

0% evidence

14.4/20Relative strength

RS sector 5% · RS bench 10.8% · 1Y 76.3%

70% evidence

16. Carlsmed, Inc. · CARL

45.2/100 · Thin evidence · provisional · 56% evidence

Exact sum: 21.3 + 7.2 + 10 + 6.7 = 45.2

Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

21.3/35Growth & earnings

Revenue 75% · PAT — · OPM change -1.5 pp

62% evidence

7.2/25Capital efficiency

ROCE -11.7% · debt/equity 0.18×

80% evidence

10.0/20Valuation

P/E — · PEG —

0% evidence

6.7/20Relative strength

RS sector -9.9% · RS bench -6.3% · 1Y -9.5%

70% evidence

17. NRC Health · NRC

45.0/100 · Mixed-negative evidence · 66% evidence

Exact sum: 6.7 + 12.7 + 9.9 + 15.7 = 45

Decision use: Price leads the evidence: RS versus the benchmark is 22.6%, but earnings trajectory is weak. Wait for revenue and profit confirmation.

6.7/35Growth & earnings

Revenue -2.1% · PAT -64% · OPM change -9.6 pp

83% evidence

12.7/25Capital efficiency

ROCE 5.8% · debt/equity 6×

80% evidence

9.9/20Valuation

P/E 43.5× · PEG —

15% evidence

15.7/20Relative strength

RS sector 16.5% · RS bench 22.6% · 1Y 77.6%

70% evidence

18. TruBridge, Inc. · TBRG

44.4/100 · Thin evidence · provisional · 59% evidence

Exact sum: 11 + 9.4 + 9.2 + 14.8 = 44.4

Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

11.0/35Growth & earnings

Revenue 0% · PAT — · OPM change -5.9 pp

62% evidence

9.4/25Capital efficiency

ROCE 0.9% · debt/equity 0.93×

80% evidence

9.2/20Valuation

P/E 73.2× · PEG —

15% evidence

14.8/20Relative strength

RS sector 5.2% · RS bench 11% · 1Y 18.9%

70% evidence

19. Talkspace, Inc. · TALK

43.9/100 · Mixed-negative evidence · 65% evidence

Exact sum: 12.8 + 10.3 + 8.5 + 12.3 = 43.9

Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

12.8/35Growth & earnings

Revenue 22.7% · PAT -66.7% · OPM change -9.5 pp

62% evidence

10.3/25Capital efficiency

ROCE -6.2% · debt/equity 0×

80% evidence

8.5/20Valuation

P/E 517.5× · PEG —

15% evidence

12.3/20Relative strength

RS sector 11.3% · RS bench 19.1% · 1Y 125.5%

100% evidence

20. Doximity, Inc. · DOCS

42.1/100 · Mixed-negative evidence · 82% evidence

Exact sum: 11.7 + 17.3 + 11.3 + 1.8 = 42.1

Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

11.7/35Growth & earnings

Revenue 13% · PAT -11.7% · OPM change -18.1 pp

83% evidence

17.3/25Capital efficiency

ROCE 2.4% · debt/equity 0.01×

80% evidence

11.3/20Valuation

P/E 23.8× · PEG 1.84

65% evidence

1.8/20Relative strength

RS sector -51.2% · RS bench -50.9% · 1Y -62.6%

100% evidence

21. Tempus AI, Inc. · TEM

39.2/100 · Mixed-negative evidence · 62% evidence

Exact sum: 23.4 + 4.3 + 10 + 1.5 = 39.2

Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -38.8% and the one-year return is -21.8%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.

23.4/35Growth & earnings

Revenue 69.7% · PAT — · OPM change 2.6 pp

62% evidence

4.3/25Capital efficiency

ROCE -5.6% · debt/equity 3.17×

80% evidence

10.0/20Valuation

P/E — · PEG —

0% evidence

1.5/20Relative strength

RS sector -38.8% · RS bench -37.1% · 1Y -21.8%

100% evidence

22. Schrödinger, Inc. · SDGR

38.9/100 · Thin evidence · provisional · 59% evidence

Exact sum: 15.9 + 7.2 + 9.6 + 6.2 = 38.9

Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

15.9/35Growth & earnings

Revenue 10.9% · PAT — · OPM change 2.2 pp

62% evidence

7.2/25Capital efficiency

ROCE -9.4% · debt/equity 0.34×

80% evidence

9.6/20Valuation

P/E 66.3× · PEG —

15% evidence

6.2/20Relative strength

RS sector -14% · RS bench -11.4% · 1Y -21.7%

70% evidence

23. GoodRx Holdings, Inc. · GDRX

38.2/100 · Mixed-negative evidence · 66% evidence

Exact sum: 9.2 + 10.6 + 10.6 + 7.8 = 38.2

Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

9.2/35Growth & earnings

Revenue -1.3% · PAT -31% · OPM change -4.3 pp

83% evidence

10.6/25Capital efficiency

ROCE 1.2% · debt/equity 0.87×

80% evidence

10.6/20Valuation

P/E 32.7× · PEG —

15% evidence

7.8/20Relative strength

RS sector -4.8% · RS bench -2.3% · 1Y -31.1%

70% evidence

24. Spok Holdings, Inc. · SPOK

38.0/100 · Mixed-negative evidence · 76% evidence

Exact sum: 8.9 + 14.6 + 9.7 + 4.8 = 38

Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

8.9/35Growth & earnings

Revenue -1.4% · PAT -18.8% · OPM change -9.2 pp

83% evidence

14.6/25Capital efficiency

ROCE 1.6% · debt/equity 0.04×

80% evidence

9.7/20Valuation

P/E 18.2× · PEG 2.25

65% evidence

4.8/20Relative strength

RS sector -26.3% · RS bench -23.8% · 1Y -41.2%

70% evidence

25. Certara, Inc. · CERT

37.0/100 · Thin evidence · provisional · 59% evidence

Exact sum: 12 + 10.1 + 8.7 + 6.2 = 37

Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

12.0/35Growth & earnings

Revenue 6.8% · PAT — · OPM change -11.2 pp

62% evidence

10.1/25Capital efficiency

ROCE -0.3% · debt/equity 0.29×

80% evidence

8.7/20Valuation

P/E 174.6× · PEG —

15% evidence

6.2/20Relative strength

RS sector -13.8% · RS bench -11.8% · 1Y -17.1%

70% evidence

26. Claritev Corporation · CTEV

34.7/100 · Thin evidence · provisional · 56% evidence

Exact sum: 13.2 + 8.2 + 10 + 3.3 = 34.7

Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

13.2/35Growth & earnings

Revenue 5.8% · PAT — · OPM change -3.1 pp

62% evidence

8.2/25Capital efficiency

ROCE 0.1% · debt/equity 1.27×

80% evidence

10.0/20Valuation

P/E — · PEG —

0% evidence

3.3/20Relative strength

RS sector -43.6% · RS bench -43.4% · 1Y -41.1%

70% evidence

27. LifeMD, Inc. · LFMD

33.3/100 · Thin evidence · provisional · 59% evidence

Exact sum: 12.3 + 6.2 + 9.4 + 5.4 = 33.3

Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

12.3/35Growth & earnings

Revenue 36.9% · PAT — · OPM change -15.5 pp

62% evidence

6.2/25Capital efficiency

ROCE -53.7% · debt/equity 0.4×

80% evidence

9.4/20Valuation

P/E 72.2× · PEG —

15% evidence

5.4/20Relative strength

RS sector -23.4% · RS bench -21.3% · 1Y -61.4%

70% evidence

28. Evolent Health, Inc. · EVH

32.0/100 · Thin evidence · provisional · 56% evidence

Exact sum: 11.3 + 6.4 + 10 + 4.3 = 32

Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

11.3/35Growth & earnings

Revenue -21.3% · PAT — · OPM change -1.8 pp

62% evidence

6.4/25Capital efficiency

ROCE -0.6% · debt/equity 2.49×

80% evidence

10.0/20Valuation

P/E — · PEG —

0% evidence

4.3/20Relative strength

RS sector -31.9% · RS bench -31.4% · 1Y -62.5%

70% evidence

29. HeartFlow, Inc. · HTFL

47.7/100 · Thin evidence · provisional · 42% evidence

Exact sum: 20.1 + 7.6 + 10 + 10 = 47.7

Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

20.1/35Growth & earnings

Revenue 40.4% · PAT — · OPM change -9.1 pp

62% evidence

7.6/25Capital efficiency

ROCE -13.2% · debt/equity 0.09×

80% evidence

10.0/20Valuation

P/E — · PEG —

0% evidence

10.0/20Relative strength

RS sector — · RS bench — · 1Y -17.9%

0% evidence

01 · compare level, then change

Revenue Scale & Growth Durability

BrightSpring Health Services, Inc. has the highest Revenue among the 29 Health Information Services companies compared here, at $13,647 million. Veeva Systems Inc. is next at $3,319 million. Carlsmed, Inc. has the highest Revenue growth at 75%, so level and change sit with different companies. 28 of 29 companies report a comparable reading, the latest through Mar 2026.

What the numbers say: BrightSpring Health Services, Inc. is the scale leader at $13,647 million, 311.2% ahead of Veeva Systems Inc.. Carlsmed, Inc.'s growth is 75% from a $56 million base, with 13 reported observations in the 20-quarter window. Treat the growth leader as an acceleration candidate, not as equally proven scale.

LeaderBrightSpring Health Services, Inc. · $13,647 million
Gap311.2% versus #2 · Veeva Systems Inc.
Persistence8/8 recent comparable periods
Coverage28/29 companies · 522 observations

Investor read: BrightSpring Health Services, Inc. is the scale benchmark; Carlsmed, Inc. is the acceleration watch. Promote the challenger only if growth persists and converts into margin and returns.

This conclusion weakens if: BrightSpring Health Services, Inc.'s growth falls below Carlsmed, Inc.'s for two consecutive comparable reports while operating margin also compresses.

Revenue is compared on a common reported-currency basis. Growth is year-on-year, so seasonality does not masquerade as progress.
Revenuelargest
1BrightSpring Health Services, Inc. BTSG$13.6B
2Veeva Systems Inc. VEEV$3.3B
3Teladoc Health, Inc. TDOC$2.5B
4Privia Health Group, Inc. PRVA$2.2B
5Evolent Health, Inc. EVH$1.9B
Revenue growthfastest growers
1Carlsmed, Inc. CARL75%
2Tempus AI, Inc. TEM70%
3Hinge Health, Inc. HNGE50%
4Omada Health, Inc. OMDA49%
5HeartFlow, Inc. HTFL40%
Revenue · company comparison
28/29 level · 28/29 change

Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.

All-company data · latest reported quarter

Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.

CompanyRevenueRevenue growthReported
BrightSpring Health Services, Inc. BTSG$3.6B26%Mar 2026
Veeva Systems Inc. VEEV$883M16%Jun 2026
Teladoc Health, Inc. TDOC$614M-2.4%Mar 2026
Privia Health Group, Inc. PRVA$604M26%Mar 2026
Evolent Health, Inc. EVH$496M2.5%Mar 2026
HealthEquity, Inc. HQY$355M7.3%Jun 2026
Tempus AI, Inc. TEM$348M36%Mar 2026
Waystar Holding Corp. WAY$314M23%Mar 2026
Omnicell, Inc. OMCL$310M15%Mar 2026
Claritev Corporation CTEV$245M6.1%Mar 2026
GoodRx Holdings, Inc. GDRX$194M-4.4%Mar 2026
Hinge Health, Inc. HNGE$182M47%Mar 2026
10x Genomics, Inc. TXG$151M-2.6%Mar 2026
Doximity, Inc. DOCS$145M5.1%Mar 2026
Phreesia, Inc. PHR$131M13%Jun 2026
Certara, Inc. CERT$107M0.9%Mar 2026
TruBridge, Inc. TBRG$86M-1.2%Mar 2026
HealthStream, Inc. HSTM$81M11%Mar 2026
Omada Health, Inc. OMDA$78M42%Mar 2026
Weave Communications, Inc. WEAV$66M18%Mar 2026
Talkspace, Inc. TALK$62M19%Mar 2026
Schrödinger, Inc. SDGR$59M-1.7%Mar 2026
HeartFlow, Inc. HTFL$53M43%Mar 2026
LifeMD, Inc. LFMD$50M-2.0%Mar 2026
NRC Health NRC$35M2.9%Mar 2026
Spok Holdings, Inc. SPOK$33M-8.3%Mar 2026
Simulations Plus, Inc. SLP$24M9.1%Jun 2026
SOPHiA GENETICS SA SOPH$22M22%Mar 2026
Carlsmed, Inc. CARL$16M60%Mar 2026
Full 20-quarter history · every available company

Revenue · reported quarter history

Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.

10x Genomics, Inc. · TXG

$125M
$144M
$114M
$115M
$131M
$156M
$134M
$147M
$154M
$184M
$141M
$153M
$152M
$165M
$155M
$173M
$149M
$166M
$151M

BrightSpring Health Services, Inc. · BTSG

$1.7B
$1.8B
$1.8B
$1.9B
$2.0B
$2.0B
$2.0B
$2.2B
$2.3B
$2.4B
$2.3B
$2.4B
$2.6B
$2.7B
$2.9B
$3.1B
$3.3B
$3.6B
$3.6B

Doximity, Inc. · DOCS

$79M
$98M
$94M
$91M
$102M
$115M
$111M
$108M
$114M
$135M
$118M
$127M
$137M
$169M
$138M
$146M
$169M
$185M
$145M

HealthEquity, Inc. · HQY

$189M
$180M
$203M
$206M
$206M
$216M
$234M
$244M
$244M
$249M
$262M
$288M
$300M
$300M
$312M
$331M
$326M
$322M
$335M
$355M

HeartFlow, Inc. · HTFL

$27M
$31M
$33M
$35M
$37M
$43M
$46M
$49M
$53M

Hinge Health, Inc. · HNGE

$124M
$70M
$81M
$82M
$83M
$90M
$101M
$117M
$124M
$139M
$154M
$171M
$182M

Omnicell, Inc. · OMCL

$296M
$311M
$319M
$331M
$348M
$298M
$291M
$299M
$299M
$259M
$246M
$277M
$282M
$307M
$270M
$291M
$311M
$314M
$310M

Privia Health Group, Inc. · PRVA

$252M
$275M
$314M
$336M
$343M
$364M
$386M
$413M
$417M
$441M
$415M
$422M
$438M
$461M
$480M
$521M
$580M
$541M
$604M

Teladoc Health, Inc. · TDOC

$522M
$554M
$565M
$592M
$611M
$638M
$629M
$652M
$660M
$661M
$646M
$642M
$641M
$640M
$629M
$632M
$626M
$642M
$614M

Tempus AI, Inc. · TEM

$52M
$63M
$64M
$78M
$88M
$101M
$116M
$132M
$136M
$148M
$146M
$166M
$181M
$201M
$256M
$315M
$334M
$367M
$348M

Veeva Systems Inc. · VEEV

$456M
$476M
$485M
$505M
$534M
$552M
$563M
$526M
$590M
$617M
$631M
$650M
$676M
$699M
$721M
$759M
$789M
$811M
$836M
$883M

Waystar Holding Corp. · WAY

$147M
$163M
$171M
$173M
$178M
$182M
$191M
$196M
$197M
$207M
$225M
$235M
$240M
$244M
$256M
$271M
$269M
$304M
$314M

Revenue growth · reported quarter history

Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.

10x Genomics, Inc. · TXG

-0.9%
4.8%
8.3%
18%
28%
18%
18%
5.2%
4.1%
-1.3%
-10%
9.9%
13%
-2.0%
0.6%
-2.6%

BrightSpring Health Services, Inc. · BTSG

23%
14%
9.4%
11%
12%
14%
21%
13%
13%
15%
16%
26%
29%
28%
29%
26%

Doximity, Inc. · DOCS

25%
29%
17%
18%
19%
12%
17%
6.3%
18%
20%
25%
17%
15%
23%
9.5%
5.1%

HealthEquity, Inc. · HQY

9.0%
20%
15%
18%
18%
15%
12%
18%
23%
20%
19%
15%
8.7%
7.3%
7.4%
7.3%

HeartFlow, Inc. · HTFL

37%
39%
39%
40%
43%

Hinge Health, Inc. · HNGE

-33%
29%
25%
43%
49%
54%
52%
46%
47%

Omnicell, Inc. · OMCL

21%
18%
-4.2%
-8.8%
-9.7%
-14%
-13%
-15%
-7.4%
-5.7%
19%
9.8%
5.1%
10%
2.3%
15%

Privia Health Group, Inc. · PRVA

49%
36%
32%
23%
23%
22%
21%
7.5%
2.2%
5.0%
4.5%
16%
23%
32%
17%
26%

Teladoc Health, Inc. · TDOC

18%
17%
15%
11%
10%
8.0%
3.6%
2.7%
-1.5%
-2.9%
-3.2%
-2.6%
-1.6%
-2.3%
0.3%
-2.4%

Tempus AI, Inc. · TEM

26%
69%
60%
81%
69%
55%
47%
26%
26%
33%
36%
75%
90%
85%
83%
36%

Veeva Systems Inc. · VEEV

17%
16%
16%
4.2%
10%
12%
12%
24%
15%
13%
14%
17%
17%
16%
16%
16%

Waystar Holding Corp. · WAY

27%
21%
12%
12%
13%
11%
14%
18%
20%
22%
18%
14%
15%
12%
25%
23%
02 · compare level, then change

Operating Economics & Margin Trend

Veeva Systems Inc. has the highest OPM among the 29 Health Information Services companies compared here, at 30.9%. HealthEquity, Inc. is next at 29%. 10x Genomics, Inc. has the highest Margin change at +14.1 percentage points, so level and change sit with different companies. 29 of 29 companies report a comparable reading, the latest through Jun 2026.

What the numbers say: Veeva Systems Inc. leads opm at 30.9%; 10x Genomics, Inc. leads margin change at +14.1 percentage points.

LeaderVeeva Systems Inc. · 30.9%
Gap6.6% versus #2 · HealthEquity, Inc.
Persistence7/8 recent comparable periods
Coverage29/29 companies · 521 observations

Investor read: Veeva Systems Inc. sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current margin change signal.

Operating margin compares operating profit with revenue. Improvement is measured in percentage points, not percentage growth.
OPMhighest
1Veeva Systems Inc. VEEV31%
2HealthEquity, Inc. HQY29%
3Waystar Holding Corp. WAY26%
4Simulations Plus, Inc. SLP23%
5Hinge Health, Inc. HNGE18%
Margin changefastest expanders
110x Genomics, Inc. TXG+14.1 pp
2Simulations Plus, Inc. SLP+11.1 pp
3SOPHiA GENETICS SA SOPH+10.5 pp
4Omnicell, Inc. OMCL+9.7 pp
5Omada Health, Inc. OMDA+9.2 pp
Operating margin · company comparison
29/29 level · 29/29 change

Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.

All-company data · latest reported quarter

Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.

CompanyOPMMargin changeReported
Veeva Systems Inc. VEEV31%+0.1 ppJun 2026
HealthEquity, Inc. HQY29%+3.9 ppJun 2026
Waystar Holding Corp. WAY26%+0.2 ppMar 2026
Simulations Plus, Inc. SLP23%+11.1 ppJun 2026
Hinge Health, Inc. HNGE18%+7.0 ppMar 2026
Doximity, Inc. DOCS17%−18.1 ppMar 2026
NRC Health NRC16%−9.6 ppMar 2026
HealthStream, Inc. HSTM9.3%+3.3 ppMar 2026
Spok Holdings, Inc. SPOK7.4%−9.2 ppMar 2026
GoodRx Holdings, Inc. GDRX7.2%−4.3 ppMar 2026
Omnicell, Inc. OMCL5.4%+9.7 ppMar 2026
Phreesia, Inc. PHR5.2%+8.0 ppJun 2026
TruBridge, Inc. TBRG3.5%−5.9 ppMar 2026
BrightSpring Health Services, Inc. BTSG3.4%+1.6 ppMar 2026
Claritev Corporation CTEV2.7%−3.1 ppMar 2026
Privia Health Group, Inc. PRVA1.2%+0.1 ppMar 2026
Evolent Health, Inc. EVH-2.1%−1.8 ppMar 2026
Certara, Inc. CERT-4.0%−11.2 ppMar 2026
Omada Health, Inc. OMDA-6.1%+9.2 ppMar 2026
Weave Communications, Inc. WEAV-9.2%+7.5 ppMar 2026
Teladoc Health, Inc. TDOC-10%+9.1 ppMar 2026
10x Genomics, Inc. TXG-11%+14.1 ppMar 2026
Talkspace, Inc. TALK-12%−9.5 ppMar 2026
LifeMD, Inc. LFMD-18%−15.5 ppMar 2026
Tempus AI, Inc. TEM-24%+2.6 ppMar 2026
HeartFlow, Inc. HTFL-56%−9.1 ppMar 2026
Carlsmed, Inc. CARL-58%−1.5 ppMar 2026
SOPHiA GENETICS SA SOPH-80%+10.5 ppMar 2026
Schrödinger, Inc. SDGR-83%+2.2 ppMar 2026
Full 20-quarter history · every available company

OPM · reported quarter history

Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.

10x Genomics, Inc. · TXG

-13%
-11%
-37%
-55%
-31%
-15%
-39%
-43%
-62%
-30%
-44%
-27%
-27%
-30%
-25%
17%
-22%
-12%
-11%

BrightSpring Health Services, Inc. · BTSG

3.9%
3.5%
3.3%
3.5%
1.8%
1.2%
2.5%
3.7%
-2.3%
2.9%
-0.7%
1.6%
1.1%
2.0%
1.8%
1.5%
2.6%
3.0%
3.4%

Doximity, Inc. · DOCS

31%
37%
30%
24%
31%
33%
30%
27%
30%
43%
36%
36%
39%
47%
35%
37%
38%
39%
17%

HealthEquity, Inc. · HQY

-0.5%
-0.2%
-13%
-3.5%
-1.2%
2.6%
5.7%
9.5%
10%
12%
15%
15%
20%
6.5%
14%
25%
28%
24%
21%
29%

HeartFlow, Inc. · HTFL

-60%
-46%
-45%
-46%
-47%
-32%
-33%
-36%
-56%

Hinge Health, Inc. · HNGE

11%
-53%
-27%
-37%
-38%
-20%
-3.8%
36%
11%
-418%
-4.0%
16%
18%

Omnicell, Inc. · OMCL

9.9%
3.7%
1.6%
3.8%
5.3%
-13%
-7.9%
2.6%
1.2%
-9.0%
-8.9%
1.2%
2.3%
4.0%
-4.3%
2.8%
2.7%
0.1%
5.4%

Privia Health Group, Inc. · PRVA

-5.1%
-7.0%
-3.7%
-1.6%
-1.3%
0.6%
1.7%
1.7%
1.3%
0.3%
0.2%
1.2%
1.3%
1.1%
1.1%
0.6%
2.5%
2.1%
1.2%

Teladoc Health, Inc. · TDOC

-12%
2.0%
-523%
-12%
-586%
-12%
-11%
-9.8%
-5.3%
-14%
-131%
-6.9%
-7.5%
-19%
-8.6%
-8.3%
-5.6%
-10%

Tempus AI, Inc. · TEM

-123%
-87%
-120%
-85%
-72%
-58%
-47%
-34%
-33%
-35%
-37%
-321%
-30%
-25%
-27%
-20%
-18%
-17%
-24%

Veeva Systems Inc. · VEEV

27%
28%
25%
25%
19%
22%
19%
12%
18%
21%
21%
24%
25%
44%
-21%
31%
25%
45%
-18%
31%

Waystar Holding Corp. · WAY

11%
7.2%
9.0%
12%
14%
16%
18%
19%
16%
18%
16%
3.5%
11%
22%
25%
24%
22%
19%
26%

Margin change · reported quarter history

Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.

10x Genomics, Inc. · TXG

−46.2 pp
−17.8 pp
−3.8 pp
−2.2 pp
+11.9 pp
−31.2 pp
−15.2 pp
−4.9 pp
+15.9 pp
+34.3 pp
−0.2 pp
+18.2 pp
+44.7 pp
+5.8 pp
+18.4 pp
+14.1 pp

BrightSpring Health Services, Inc. · BTSG

+0.2 pp
−2.1 pp
−2.3 pp
−0.8 pp
+0.2 pp
−4.1 pp
+1.7 pp
−3.2 pp
−2.1 pp
+3.4 pp
−0.9 pp
+2.5 pp
−0.1 pp
+1.5 pp
+1.0 pp
+1.6 pp

Doximity, Inc. · DOCS

−10.3 pp
0.0 pp
−3.2 pp
−0.2 pp
+3.5 pp
−1.7 pp
+9.9 pp
+5.9 pp
+9.0 pp
+9.1 pp
+4.1 pp
−0.3 pp
+1.0 pp
−1.0 pp
−8.5 pp
−18.1 pp

HealthEquity, Inc. · HQY

−0.7 pp
+2.8 pp
+19.1 pp
+13.0 pp
+11.4 pp
+9.8 pp
+9.1 pp
+5.0 pp
+9.4 pp
−5.9 pp
−1.3 pp
+10.6 pp
+7.9 pp
+17.9 pp
+7.7 pp
+3.9 pp

HeartFlow, Inc. · HTFL

+12.8 pp
+14.1 pp
+12.7 pp
+9.8 pp
−9.1 pp

Hinge Health, Inc. · HNGE

−48.6 pp
+33.7 pp
+23.6 pp
+73.1 pp
+48.6 pp
−398.0 pp
−0.2 pp
−19.7 pp
+7.0 pp

Omnicell, Inc. · OMCL

−6.8 pp
−4.6 pp
−16.6 pp
−9.5 pp
−1.2 pp
−4.1 pp
+3.9 pp
−1.0 pp
−1.4 pp
+1.1 pp
+13.0 pp
+4.6 pp
+1.6 pp
+0.4 pp
−3.9 pp
+9.7 pp

Privia Health Group, Inc. · PRVA

+84.0 pp
+3.8 pp
+7.6 pp
+5.4 pp
+3.3 pp
+2.6 pp
−0.3 pp
−1.5 pp
−0.5 pp
0.0 pp
+0.8 pp
+0.9 pp
−0.6 pp
+1.2 pp
+1.0 pp
+0.1 pp

Teladoc Health, Inc. · TDOC

−507.0 pp
−0.1 pp
−588.4 pp
+1,167.4 pp
+511.7 pp
+1.9 pp
+581.1 pp
−1.2 pp
−119.9 pp
+2.9 pp
−2.2 pp
−5.7 pp
+122.3 pp
−1.4 pp
+1.9 pp
+9.1 pp

Tempus AI, Inc. · TEM

+16.4 pp
+51.0 pp
+28.2 pp
+73.5 pp
+50.9 pp
+39.3 pp
+22.9 pp
+10.1 pp
−287.3 pp
+3.3 pp
+10.1 pp
+9.6 pp
+301.8 pp
+11.3 pp
+8.6 pp
+2.6 pp

Veeva Systems Inc. · VEEV

−8.5 pp
−5.9 pp
−5.4 pp
−13.6 pp
−1.3 pp
−1.2 pp
+2.1 pp
+12.2 pp
+7.0 pp
+22.7 pp
−42.7 pp
+6.9 pp
+0.2 pp
+1.5 pp
+3.2 pp
+0.1 pp

Waystar Holding Corp. · WAY

−0.5 pp
+3.2 pp
+8.5 pp
+9.3 pp
+6.8 pp
+2.6 pp
+2.5 pp
−2.6 pp
−15.5 pp
−5.0 pp
+3.6 pp
+9.7 pp
+20.5 pp
+11.1 pp
−2.4 pp
+0.2 pp
03 · compare level, then change

Profit Scale & Acceleration

Veeva Systems Inc. has the highest Net profit among the 29 Health Information Services companies compared here, at $941 million. HealthEquity, Inc. is next at $231 million. Waystar Holding Corp. has the highest Profit growth at the 100% top of the scoring scale, so level and change sit with different companies.

What the numbers say: Veeva Systems Inc. leads with $941 million of TTM profit, 307.4% above HealthEquity, Inc.. Waystar Holding Corp. shows ≥100% on the scoring scale (404% uncapped) growth from a $126 million profit base. Compare the size of the base and persistence before ranking acceleration above profit scale.

LeaderVeeva Systems Inc. · $941 million
Gap307.4% versus #2 · HealthEquity, Inc.
Persistence8/8 recent comparable periods
Coverage28/29 companies · 522 observations

Investor read: Veeva Systems Inc. sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current profit growth signal.

Net profit is the residual after operating costs, interest and tax. Growth off a loss or near-zero base is excluded from the fastest-grower rank.
Net profitlargest
1Veeva Systems Inc. VEEV$941M
2HealthEquity, Inc. HQY$231M
3Doximity, Inc. DOCS$196M
4BrightSpring Health Services, Inc. BTSG$170M
5Waystar Holding Corp. WAY$126M
Profit growthfastest growers
1Waystar Holding Corp. WAY100%
2HealthEquity, Inc. HQY89%
3Privia Health Group, Inc. PRVA40%
4Veeva Systems Inc. VEEV21%
5HealthStream, Inc. HSTM5.3%
Net profit · company comparison
28/29 level · 10/29 change

Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.

All-company data · latest reported quarter

Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.

CompanyNet profitProfit growthReported
Veeva Systems Inc. VEEV$261M14%Jun 2026
BrightSpring Health Services, Inc. BTSG$74M722%Mar 2026
HealthEquity, Inc. HQY$69M28%Jun 2026
Waystar Holding Corp. WAY$43M48%Mar 2026
Hinge Health, Inc. HNGE$35M106%Mar 2026
Doximity, Inc. DOCS$19M-69%Mar 2026
Omnicell, Inc. OMCL$11M-113%Mar 2026
HealthStream, Inc. HSTM$6M50%Mar 2026
Simulations Plus, Inc. SLP$5M67%Jun 2026
Privia Health Group, Inc. PRVA$4M-33%Mar 2026
Phreesia, Inc. PHR$3M18%Jun 2026
NRC Health NRC$3M-50%Mar 2026
Spok Holdings, Inc. SPOK$2M-60%Mar 2026
GoodRx Holdings, Inc. GDRX$1M-91%Mar 2026
TruBridge, Inc. TBRG$1M-167%Mar 2026
Omada Health, Inc. OMDA$-3MMar 2026
Talkspace, Inc. TALK$-6M400%Mar 2026
Weave Communications, Inc. WEAV$-6MMar 2026
Certara, Inc. CERT$-9M-280%Mar 2026
Carlsmed, Inc. CARL$-9MMar 2026
LifeMD, Inc. LFMD$-9M-107%Mar 2026
10x Genomics, Inc. TXG$-13MMar 2026
SOPHiA GENETICS SA SOPH$-19MMar 2026
HeartFlow, Inc. HTFL$-27MMar 2026
Evolent Health, Inc. EVH$-27M-1,100%Mar 2026
Schrödinger, Inc. SDGR$-60M-1,450%Mar 2026
Teladoc Health, Inc. TDOC$-64MMar 2026
Tempus AI, Inc. TEM$-123MMar 2026
Claritev Corporation CTEV$-147M-220%Mar 2026
Full 20-quarter history · every available company

Net profit · reported quarter history

Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.

10x Genomics, Inc. · TXG

$-17M
$-18M
$-42M
$-64M
$-42M
$-17M
$-51M
$-62M
$-93M
$-49M
$-60M
$-38M
$-36M
$-49M
$-34M
$35M
$-27M
$-16M
$-13M

BrightSpring Health Services, Inc. · BTSG

$17M
$15M
$11M
$14M
$-23M
$-57M
$-22M
$3M
$-130M
$-7M
$-56M
$8M
$-26M
$4M
$9M
$9M
$37M
$50M
$74M

Doximity, Inc. · DOCS

$36M
$56M
$37M
$22M
$26M
$33M
$31M
$28M
$31M
$48M
$41M
$41M
$44M
$75M
$62M
$53M
$62M
$62M
$19M

HealthEquity, Inc. · HQY

$-4M
$-5M
$-33M
$-14M
$-11M
$-2M
$0M
$4M
$11M
$15M
$26M
$29M
$36M
$6M
$26M
$54M
$60M
$52M
$50M
$69M

HeartFlow, Inc. · HTFL

$-21M
$-23M
$-19M
$-33M
$-32M
$-9M
$-51M
$-24M
$-27M

Hinge Health, Inc. · HNGE

$17M
$-32M
$-17M
$-24M
$-26M
$-13M
$0M
$27M
$17M
$-576M
$-2M
$32M
$35M

Omnicell, Inc. · OMCL

$29M
$14M
$8M
$9M
$17M
$-28M
$-15M
$3M
$6M
$-14M
$-16M
$4M
$9M
$16M
$-7M
$6M
$5M
$-2M
$11M

Privia Health Group, Inc. · PRVA

$-11M
$-12M
$-18M
$-11M
$1M
$17M
$6M
$6M
$6M
$2M
$3M
$5M
$4M
$5M
$6M
$3M
$10M
$11M
$4M

Teladoc Health, Inc. · TDOC

$-84M
$-11M
$-6.7B
$-3.1B
$-73M
$-3.8B
$-69M
$-65M
$-57M
$-29M
$-82M
$-838M
$-33M
$-48M
$-93M
$-33M
$-50M
$-25M
$-64M

Tempus AI, Inc. · TEM

$-65M
$-55M
$-77M
$-67M
$-63M
$-59M
$-54M
$-56M
$-53M
$-50M
$-65M
$-552M
$-74M
$-10M
$-66M
$-41M
$-82M
$-51M
$-123M

Veeva Systems Inc. · VEEV

$109M
$106M
$97M
$100M
$91M
$108M
$189M
$132M
$112M
$135M
$147M
$162M
$171M
$186M
$196M
$228M
$200M
$236M
$244M
$261M

Waystar Holding Corp. · WAY

$-12M
$-15M
$-15M
$-11M
$-10M
$-16M
$-11M
$-11M
$-15M
$-14M
$-16M
$-28M
$5M
$19M
$29M
$32M
$31M
$20M
$43M

Profit growth · reported quarter history

Showing the 12 largest of 21 companies with a series here. The remaining 9 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.

BrightSpring Health Services, Inc. · BTSG

56%
-235%
-480%
-300%
-79%
167%
13%
1,150%
722%

Certara, Inc. · CERT

-50%
-1,325%
-233%
-600%
-360%
-186%
-280%

Doximity, Inc. · DOCS

-15%
-28%
-41%
-16%
27%
19%
45%
32%
46%
42%
56%
51%
29%
41%
-17%
-69%

GoodRx Holdings, Inc. · GDRX

-103%
-125%
-88%
86%
-75%
-29%
-91%

HealthEquity, Inc. · HQY

625%
227%
-60%
0.0%
86%
67%
767%
92%
28%

Hinge Health, Inc. · HNGE

-253%
19%
106%

Omnicell, Inc. · OMCL

-55%
-41%
-300%
-288%
-67%
-65%
33%
50%
50%
-44%
-113%

Privia Health Group, Inc. · PRVA

500%
-88%
-50%
-17%
-33%
150%
100%
-40%
150%
120%
-33%

Schrödinger, Inc. · SDGR

-143%
-1,450%

Talkspace, Inc. · TALK

-177%
-1,000%
-117%
50%
400%

Veeva Systems Inc. · VEEV

-17%
1.9%
95%
32%
23%
25%
-22%
23%
53%
38%
33%
41%
17%
27%
24%
14%

Waystar Holding Corp. · WAY

520%
5.3%
48%
04 · compare level, then change

Capacity Spending & Returns On It

Claritev Corporation has the highest CAPEX among the 29 Health Information Services companies compared here, at $47 million. BrightSpring Health Services, Inc. is next at $22 million. The same company also holds the highest CAPEX intensity, at 19.2%. 28 of 29 companies report a comparable reading, the latest through Mar 2026.

What the numbers say: Claritev Corporation reports $47 million of CAPEX; Claritev Corporation has the highest covered intensity at 19.2%. Coverage is only 28 of 29 companies and 453 reported observations, so this is partial evidence—not a complete sector rank.

LeaderClaritev Corporation · $47 million
Gap113.6% versus #2 · BrightSpring Health Services, Inc.
Persistence8/8 recent comparable periods
Coverage28/29 companies · 453 observations

Investor read: Use the CAPEX rank as a diligence queue. Verify commissioning, utilization, cash conversion and post-investment ROCE before treating spend as value creation.

This conclusion weakens if: CAPEX rises without higher utilization, operating cash flow or incremental returns.

CAPEX is cash spent on property, plant, equipment and other reported capital assets. CAPEX intensity divides that spend by revenue; high intensity is a reinvestment signal, not proof that the reinvestment will earn attractive returns.
CAPEXlargest spenders
1Claritev Corporation CTEV$47M
2BrightSpring Health Services, Inc. BTSG$22M
3Waystar Holding Corp. WAY$15M
4Omnicell, Inc. OMCL$12M
5Tempus AI, Inc. TEM$8M
CAPEX intensityhighest reinvestment intensity
1Claritev Corporation CTEV19%
2NRC Health NRC5.7%
3Schrödinger, Inc. SDGR5.1%
4Waystar Holding Corp. WAY4.8%
5SOPHiA GENETICS SA SOPH4.5%
Capital expenditure · company comparison
28/29 level · 28/29 change

Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.

All-company data · latest reported quarter

Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.

CompanyCAPEXCAPEX intensityReported
Claritev Corporation CTEV$47M19%Mar 2026
BrightSpring Health Services, Inc. BTSG$22M0.6%Mar 2026
Waystar Holding Corp. WAY$15M4.8%Mar 2026
Omnicell, Inc. OMCL$12M3.9%Mar 2026
Tempus AI, Inc. TEM$8M2.3%Mar 2026
Evolent Health, Inc. EVH$6M1.2%Mar 2026
Phreesia, Inc. PHR$4M3.1%Jun 2026
Schrödinger, Inc. SDGR$3M5.1%Mar 2026
10x Genomics, Inc. TXG$2M1.3%Mar 2026
HeartFlow, Inc. HTFL$2M3.8%Mar 2026
Teladoc Health, Inc. TDOC$2M0.3%Mar 2026
NRC Health NRC$2M5.7%Mar 2026
Certara, Inc. CERT$1M0.9%Mar 2026
GoodRx Holdings, Inc. GDRX$1M0.5%Mar 2026
HealthStream, Inc. HSTM$1M1.2%Mar 2026
Weave Communications, Inc. WEAV$1M1.5%Mar 2026
SOPHiA GENETICS SA SOPH$1M4.5%Mar 2026
TruBridge, Inc. TBRG$1M1.2%Mar 2026
Spok Holdings, Inc. SPOK$1M3.0%Mar 2026
HealthEquity, Inc. HQY$0M0.0%Jun 2026
Hinge Health, Inc. HNGE$0M0.0%Mar 2026
Doximity, Inc. DOCS$0M0.0%Mar 2026
Privia Health Group, Inc. PRVA$0M0.0%Mar 2026
Omada Health, Inc. OMDA$0M0.0%Mar 2026
Talkspace, Inc. TALK$0M0.0%Mar 2026
Simulations Plus, Inc. SLP$0M0.0%Jun 2026
Carlsmed, Inc. CARL$0M0.0%Mar 2026
LifeMD, Inc. LFMD$0M0.0%Mar 2026
Full 20-quarter history · every available company

CAPEX · reported quarter history

Showing the 12 largest of 28 companies with a series here. The remaining 16 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.

10x Genomics, Inc. · TXG

$20M
$28M
$28M
$27M
$37M
$40M
$5M
$25M
$15M
$3M
$3M
$3M
$4M
$3M
$2M
$2M
$1M
$2M
$2M

BrightSpring Health Services, Inc. · BTSG

$14M
$17M
$17M
$17M
$19M
$18M
$18M
$21M
$18M
$17M
$22M
$24M
$20M
$15M
$18M
$24M
$16M
$38M
$22M

Certara, Inc. · CERT

$0M
$0M
$1M
$0M
$0M
$0M
$0M
$0M
$0M
$1M
$1M
$0M
$0M
$0M
$1M
$0M
$0M
$1M
$1M

Doximity, Inc. · DOCS

$0M
$1M
$1M
$1M
$1M
$0M
$0M
$0M
$0M
$0M
$0M

HealthEquity, Inc. · HQY

$4M
$1M
$2M
$1M
$1M
$1M
$0M
$0M
$0M
$1M
$1M
$1M
$1M
$0M
$0M
$0M
$1M
$1M
$0M
$0M

HeartFlow, Inc. · HTFL

$2M
$1M
$1M
$0M
$1M
$1M
$1M
$2M
$2M

Hinge Health, Inc. · HNGE

$0M
$0M
$0M
$0M
$0M
$0M
$0M
$0M
$0M

Omnicell, Inc. · OMCL

$7M
$11M
$11M
$10M
$13M
$14M
$10M
$12M
$11M
$9M
$9M
$10M
$9M
$9M
$11M
$12M
$10M
$8M
$12M

Privia Health Group, Inc. · PRVA

$0M
$0M
$0M
$0M
$0M

Teladoc Health, Inc. · TDOC

$1M
$3M
$4M
$3M
$4M
$6M
$2M
$2M
$6M
$1M
$1M
$2M
$2M
$6M
$3M
$1M
$2M
$3M
$2M

Tempus AI, Inc. · TEM

$5M
$2M
$2M
$6M
$10M
$16M
$3M
$6M
$8M
$0M
$8M
$2M
$8M
$7M
$5M
$8M

Waystar Holding Corp. · WAY

$5M
$5M
$5M
$3M
$5M
$5M
$6M
$6M
$6M
$7M
$9M
$6M
$5M
$6M
$6M
$9M
$15M

CAPEX intensity · reported quarter history

Showing the 12 largest of 28 companies with a series here. The remaining 16 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.

10x Genomics, Inc. · TXG

16%
19%
25%
24%
28%
26%
3.7%
17%
9.7%
1.6%
2.1%
2.0%
2.6%
1.8%
1.3%
1.2%
0.7%
1.2%
1.3%

BrightSpring Health Services, Inc. · BTSG

0.8%
0.9%
0.9%
0.9%
1.0%
0.9%
0.9%
1.0%
0.8%
0.7%
1.0%
1.0%
0.8%
0.5%
0.6%
0.8%
0.5%
1.1%
0.6%

Certara, Inc. · CERT

0.0%
0.0%
1.2%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
1.1%
1.0%
0.0%
0.0%
0.0%
0.9%
0.0%
0.0%
1.0%
0.9%

Doximity, Inc. · DOCS

0.0%
1.0%
1.1%
1.1%
1.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%

HealthEquity, Inc. · HQY

2.1%
0.6%
1.0%
0.5%
0.5%
0.5%
0.0%
0.0%
0.0%
0.4%
0.4%
0.3%
0.3%
0.0%
0.0%
0.0%
0.3%
0.3%
0.0%
0.0%

HeartFlow, Inc. · HTFL

7.4%
3.2%
3.0%
0.0%
2.7%
2.3%
2.2%
4.1%
3.8%

Hinge Health, Inc. · HNGE

0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%

Omnicell, Inc. · OMCL

2.4%
3.5%
3.4%
3.0%
3.7%
4.7%
3.4%
4.0%
3.7%
3.5%
3.7%
3.6%
3.2%
2.9%
4.1%
4.1%
3.2%
2.5%
3.9%

Privia Health Group, Inc. · PRVA

0.0%
0.0%
0.0%
0.0%
0.0%

Teladoc Health, Inc. · TDOC

0.2%
0.5%
0.7%
0.5%
0.7%
0.9%
0.3%
0.3%
0.9%
0.2%
0.2%
0.3%
0.3%
0.9%
0.5%
0.2%
0.3%
0.5%
0.3%

Tempus AI, Inc. · TEM

9.6%
3.2%
2.0%
5.2%
7.6%
12%
2.0%
4.1%
4.8%
0.0%
4.0%
0.8%
2.5%
2.1%
1.4%
2.3%

Waystar Holding Corp. · WAY

2.9%
2.9%
2.8%
1.6%
2.6%
2.6%
3.0%
2.9%
2.7%
3.0%
3.8%
2.5%
2.0%
2.2%
2.2%
3.0%
4.8%
Annual capital allocation · 5-year view
29/29 capacity base · 29/29 OCF · 28/29 CAPEX · 29/29 FCF

Capacity base is net fixed assets plus capital work in progress, straight off the reported balance sheet. It is not cash spent, so it answers a narrower question than CAPEX — but it is reported for companies whose cash-flow CAPEX is not published, which is why it leads here. Missing years remain blank; annual values are never relabelled as quarters.

Full annual capacity base, operating cash flow, CAPEX and free cash flow history

Capacity base · net fixed assets + CWIP · fiscal-year history

Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.

10x Genomics, Inc. · TXG

$230M
$359M
$345M
$310M
$287M

Doximity, Inc. · DOCS

$10M
$25M
$25M
$23M
$25M

HeartFlow, Inc. · HTFL

$31M
$28M
$26M

Omnicell, Inc. · OMCL

$120M
$132M
$134M
$138M
$144M

Tempus AI, Inc. · TEM

$35M
$68M
$82M
$73M
$154M

Veeva Systems Inc. · VEEV

$104M
$105M
$104M
$120M
$146M

Operating cash flow · fiscal-year history

Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.

Doximity, Inc. · DOCS

$127M
$180M
$184M
$273M
$326M

HealthEquity, Inc. · HQY

$141M
$151M
$243M
$340M
$457M

HeartFlow, Inc. · HTFL

$-76M
$-69M
$-54M

Omnicell, Inc. · OMCL

$232M
$78M
$181M
$188M
$127M

Tempus AI, Inc. · TEM

$-212M
$-168M
$-214M
$-189M
$-218M

Veeva Systems Inc. · VEEV

$764M
$780M
$911M
$1.1B
$1.4B

CAPEX · reported cash flow · fiscal-year history

Showing the 12 largest of 28 companies with a series here. The remaining 16 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.

Certara, Inc. · CERT

$1M
$1M
$2M
$2M
$2M

Doximity, Inc. · DOCS

$2M
$2M
$0M

HeartFlow, Inc. · HTFL

$6M
$4M
$5M

Omnicell, Inc. · OMCL

$29M
$48M
$41M
$36M
$40M

Tempus AI, Inc. · TEM

$12M
$18M
$35M
$22M
$21M

Free cash flow · fiscal-year history

Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.

10x Genomics, Inc. · TXG

$-123M
$-165M
$-64M
$-6M
$130M

Doximity, Inc. · DOCS

$125M
$178M
$184M
$273M
$326M

HealthEquity, Inc. · HQY

$132M
$147M
$241M
$338M
$455M

HeartFlow, Inc. · HTFL

$-83M
$-73M
$-59M

Omnicell, Inc. · OMCL

$203M
$30M
$140M
$151M
$87M

Tempus AI, Inc. · TEM

$-224M
$-187M
$-249M
$-211M
$-239M

Veeva Systems Inc. · VEEV

$764M
$780M
$911M
$1.1B
$1.4B
05 · compare level, then change

Debt Load & Balance-Sheet Headroom

Omada Health, Inc. has the lowest Gross debt among the 29 Health Information Services companies compared here, at $0 million. Veeva Systems Inc. has the lowest Net debt at $7,210 million net cash, so level and change sit with different companies. 29 of 29 companies report a comparable reading, the latest through Mar 2026.

What the numbers say: Veeva Systems Inc. has the clearest covered balance-sheet capacity with $7,210 million net cash and gross debt of $103 million. Absolute debt alone does not identify the strongest balance sheet because company scale differs; net debt and debt-to-equity carry more information.

LeaderOmada Health, Inc. · $0 million
Gapnull versus #2 · Simulations Plus, Inc.
Persistence8/8 recent comparable periods
Coverage29/29 companies · 509 observations

Investor read: Prioritize net-cash capacity and leverage relative to operating scale, not the smallest absolute rupee debt.

This conclusion weakens if: Net debt rises faster than revenue and profit for two consecutive reported periods.

Gross debt shows contractual borrowings. Net debt subtracts reported cash; a negative value means net cash. Lower debt can create capacity, but should be read against the scale and capital intensity of the business.
Gross debtlowest gross debt
1Omada Health, Inc. OMDA$0M
2Simulations Plus, Inc. SLP$0M
3Talkspace, Inc. TALK$0M
4LifeMD, Inc. LFMD$6M
5Spok Holdings, Inc. SPOK$6M
Net debtlowest net debt
1Veeva Systems Inc. VEEV$-7.2B
2Doximity, Inc. DOCS$-739M
310x Genomics, Inc. TXG$-459M
4Privia Health Group, Inc. PRVA$-411M
5Hinge Health, Inc. HNGE$-309M
Debt and balance-sheet capacity · company comparison
29/29 level · 29/29 change

Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.

All-company data · latest reported quarter

Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.

CompanyGross debtNet debtReported
BrightSpring Health Services, Inc. BTSG$2.7B$1.8BMar 2026
Waystar Holding Corp. WAY$1.5B$1.3BMar 2026
Tempus AI, Inc. TEM$1.3B$680MMar 2026
Teladoc Health, Inc. TDOC$1.0B$277MMar 2026
HealthEquity, Inc. HQY$985M$720MJun 2026
Evolent Health, Inc. EVH$985M$819MMar 2026
GoodRx Holdings, Inc. GDRX$541M$305MMar 2026
Certara, Inc. CERT$300M$151MMar 2026
Omnicell, Inc. OMCL$191M$-48MMar 2026
TruBridge, Inc. TBRG$167M$132MMar 2026
Schrödinger, Inc. SDGR$107M$-299MMar 2026
Veeva Systems Inc. VEEV$103M$-7.2BJun 2026
Phreesia, Inc. PHR$93M$18MJun 2026
10x Genomics, Inc. TXG$81M$-459MMar 2026
NRC Health NRC$78M$75MMar 2026
SOPHiA GENETICS SA SOPH$62M$-3MMar 2026
Weave Communications, Inc. WEAV$51M$-22MMar 2026
HeartFlow, Inc. HTFL$26M$-132MMar 2026
Claritev Corporation CTEV$20M$-1MMar 2026
Carlsmed, Inc. CARL$17M$-80MMar 2026
HealthStream, Inc. HSTM$14M$-52MMar 2026
Doximity, Inc. DOCS$10M$-739MMar 2026
Privia Health Group, Inc. PRVA$9M$-411MMar 2026
Hinge Health, Inc. HNGE$7M$-309MMar 2026
Spok Holdings, Inc. SPOK$6M$-11MMar 2026
LifeMD, Inc. LFMD$6M$-28MMar 2026
Omada Health, Inc. OMDA$0M$-212MMar 2026
Talkspace, Inc. TALK$0M$-84MMar 2026
Simulations Plus, Inc. SLP$0M$-50MJun 2026
Full 20-quarter history · every available company

Gross debt · reported quarter history

Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.

10x Genomics, Inc. · TXG

$80M
$82M
$101M
$99M
$96M
$95M
$102M
$100M
$98M
$95M
$92M
$89M
$86M
$83M
$80M
$87M
$87M
$84M
$81M

BrightSpring Health Services, Inc. · BTSG

$3.7B
$3.8B
$3.7B
$3.7B
$3.7B
$3.7B
$3.8B
$3.7B
$2.9B
$2.9B
$3.0B
$2.8B
$2.7B
$2.7B
$2.7B
$2.7B
$2.7B

Doximity, Inc. · DOCS

$1M
$2M
$1M
$12M
$16M
$16M
$16M
$16M
$15M
$15M
$15M
$14M
$13M
$13M
$12M
$12M
$11M
$11M
$10M

HealthEquity, Inc. · HQY

$1.1B
$1.0B
$1.0B
$1.0B
$1.0B
$998M
$994M
$942M
$936M
$935M
$933M
$984M
$1.2B
$1.1B
$1.1B
$1.1B
$1.1B
$1.0B
$1.0B
$985M

HeartFlow, Inc. · HTFL

$161M
$161M
$160M
$160M
$203M
$205M
$22M
$22M
$26M

Hinge Health, Inc. · HNGE

$16M
$16M
$11M
$11M
$10M
$10M
$9M
$8M
$7M

Omnicell, Inc. · OMCL

$523M
$528M
$602M
$608M
$608M
$606M
$604M
$604M
$602M
$604M
$605M
$605M
$604M
$372M
$374M
$373M
$195M
$192M
$191M

Privia Health Group, Inc. · PRVA

$43M
$46M
$46M
$13M
$12M
$12M
$11M
$10M
$9M
$8M
$8M
$7M
$6M
$6M
$5M
$7M
$6M
$10M
$9M

Teladoc Health, Inc. · TDOC

$1.3B
$91M
$1.6B
$70M
$1.6B
$1.6B
$1.6B
$1.6B
$1.6B
$1.6B
$1.6B
$1.6B
$1.6B
$1.6B
$1.6B
$1.0B
$1.0B
$1.0B
$1.0B

Tempus AI, Inc. · TEM

$244M
$239M
$396M
$433M
$459M
$488M
$485M
$476M
$472M
$468M
$858M
$853M
$1.3B
$1.3B
$1.3B

Veeva Systems Inc. · VEEV

$59M
$56M
$55M
$54M
$63M
$62M
$61M
$58M
$59M
$58M
$56M
$56M
$54M
$72M
$76M
$77M
$85M
$90M
$96M
$103M

Waystar Holding Corp. · WAY

$2.3B
$2.3B
$2.3B
$2.3B
$2.3B
$2.3B
$2.3B
$2.3B
$2.3B
$1.4B
$1.3B
$1.3B
$1.3B
$1.3B
$1.3B
$1.5B
$1.5B

Net debt · reported quarter history

Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.

10x Genomics, Inc. · TXG

$-520M
$-506M
$-438M
$-401M
$-357M
$-338M
$-319M
$-293M
$-259M
$-294M
$-280M
$-291M
$-312M
$-310M
$-347M
$-360M
$-395M
$-439M
$-459M

BrightSpring Health Services, Inc. · BTSG

$3.4B
$3.7B
$3.7B
$3.7B
$3.7B
$3.7B
$3.8B
$3.7B
$2.8B
$2.9B
$2.9B
$2.7B
$2.7B
$2.6B
$2.6B
$2.6B
$1.8B

Doximity, Inc. · DOCS

$-742M
$-764M
$-797M
$-764M
$-734M
$-785M
$-825M
$-857M
$-715M
$-695M
$-748M
$-736M
$-793M
$-832M
$-904M
$-829M
$-867M
$-724M
$-739M

HealthEquity, Inc. · HQY

$303M
$362M
$783M
$845M
$825M
$788M
$740M
$716M
$646M
$601M
$529M
$733M
$830M
$813M
$813M
$819M
$751M
$719M
$682M
$720M

HeartFlow, Inc. · HTFL

$38M
$38M
$109M
$109M
$93M
$125M
$-269M
$-155M
$-132M

Hinge Health, Inc. · HNGE

$-407M
$-407M
$-456M
$-456M
$-461M
$-403M
$-471M
$-356M
$-309M

Omnicell, Inc. · OMCL

$41M
$179M
$337M
$363M
$342M
$276M
$264M
$205M
$155M
$136M
$93M
$48M
$33M
$3M
$-13M
$-26M
$15M
$-5M
$-48M

Privia Health Group, Inc. · PRVA

$-319M
$-275M
$-270M
$-279M
$-305M
$-336M
$-300M
$-308M
$-321M
$-382M
$-343M
$-380M
$-416M
$-485M
$-464M
$-383M
$-435M
$-470M
$-411M

Teladoc Health, Inc. · TDOC

$441M
$-805M
$747M
$-814M
$686M
$655M
$694M
$615M
$541M
$458M
$482M
$416M
$334M
$276M
$384M
$345M
$306M
$248M
$277M

Tempus AI, Inc. · TEM

$-101M
$-39M
$27M
$130M
$326M
$290M
$390M
$-14M
$6M
$20M
$639M
$562M
$576M
$572M
$680M

Veeva Systems Inc. · VEEV

$-2.2B
$-2.3B
$-2.3B
$-2.8B
$-2.9B
$-3.0B
$-3.0B
$-3.6B
$-3.8B
$-3.9B
$-4.0B
$-4.7B
$-4.8B
$-5.0B
$-5.1B
$-6.0B
$-6.3B
$-6.5B
$-6.5B
$-7.2B

Waystar Holding Corp. · WAY

$2.2B
$2.2B
$2.2B
$2.2B
$2.2B
$2.2B
$2.2B
$2.2B
$2.2B
$1.3B
$1.1B
$1.1B
$1.0B
$914M
$834M
$1.4B
$1.3B
06 · compare level, then change

Return On Capital Employed

Hinge Health, Inc. has the highest ROCE among the 29 Health Information Services companies compared here, at 8.4%. NRC Health is next at 5.8%. Simulations Plus, Inc. has the highest ROCE change at +52 percentage points, so level and change sit with different companies. 29 of 29 companies report a comparable reading, the latest through Mar 2026.

What the numbers say: Hinge Health, Inc. leads ROCE at 8.4%, 2.6 percentage points above NRC Health. Simulations Plus, Inc. has the strongest latest improvement at +52 percentage points. Read the leader beside the density of its reported history: a sparse high return is a candidate; a repeated high return is evidence of durability.

LeaderHinge Health, Inc. · 8.4%
Gap44.8% versus #2 · NRC Health
Persistence3/5 recent comparable periods
Coverage29/29 companies · 510 observations

Investor read: Hinge Health, Inc. sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current roce change signal.

ROCE asks how much operating return the business earns on the capital employed. Direction matters, but a single exceptional year should not be mistaken for durability.
ROCEhighest
1Hinge Health, Inc. HNGE8.4%
2NRC Health NRC5.8%
3Veeva Systems Inc. VEEV4.0%
4Simulations Plus, Inc. SLP3.4%
5HealthEquity, Inc. HQY3.2%
ROCE changefastest improvers
1Simulations Plus, Inc. SLP+52.0 pp
2Omada Health, Inc. OMDA+15.4 pp
3HeartFlow, Inc. HTFL+11.6 pp
4Carlsmed, Inc. CARL+11.4 pp
5Tempus AI, Inc. TEM+3.8 pp
Return on capital · company comparison
29/29 level · 29/29 change

Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.

All-company data · latest reported quarter

Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.

CompanyROCEROCE changeReported
Hinge Health, Inc. HNGE8.4%+2.5 ppMar 2026
NRC Health NRC5.8%−4.3 ppMar 2026
Veeva Systems Inc. VEEV4.0%−0.1 ppJun 2026
Simulations Plus, Inc. SLP3.4%+52.0 ppJun 2026
HealthEquity, Inc. HQY3.2%+0.6 ppJun 2026
BrightSpring Health Services, Inc. BTSG2.7%+1.5 ppMar 2026
Doximity, Inc. DOCS2.4%−2.4 ppMar 2026
HealthStream, Inc. HSTM1.9%+0.8 ppMar 2026
Phreesia, Inc. PHR1.7%+2.9 ppJun 2026
Waystar Holding Corp. WAY1.6%+0.1 ppMar 2026
Spok Holdings, Inc. SPOK1.6%−2.0 ppMar 2026
GoodRx Holdings, Inc. GDRX1.2%−0.6 ppMar 2026
Omnicell, Inc. OMCL1.1%+1.8 ppMar 2026
Privia Health Group, Inc. PRVA1.0%+0.2 ppMar 2026
TruBridge, Inc. TBRG0.9%−1.4 ppMar 2026
Claritev Corporation CTEV0.1%−0.1 ppMar 2026
Certara, Inc. CERT-0.3%−0.8 ppMar 2026
Evolent Health, Inc. EVH-0.6%−0.5 ppMar 2026
10x Genomics, Inc. TXG-2.0%+2.9 ppMar 2026
Teladoc Health, Inc. TDOC-2.5%+1.3 ppMar 2026
Omada Health, Inc. OMDA-2.9%+15.4 ppMar 2026
Weave Communications, Inc. WEAV-5.1%+2.8 ppMar 2026
Tempus AI, Inc. TEM-5.6%+3.8 ppMar 2026
Talkspace, Inc. TALK-6.2%−5.3 ppMar 2026
Schrödinger, Inc. SDGR-9.4%−1.0 ppMar 2026
Carlsmed, Inc. CARL-12%+11.4 ppMar 2026
HeartFlow, Inc. HTFL-13%+11.6 ppMar 2026
SOPHiA GENETICS SA SOPH-15%−3.1 ppMar 2026
LifeMD, Inc. LFMD-54%−45.7 ppMar 2026
Full 20-quarter history · every available company

ROCE · reported quarter history

Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.

10x Genomics, Inc. · TXG

-1.8%
-1.8%
-4.8%
-7.2%
-4.5%
-2.6%
-5.7%
-7.1%
-11%
-6.4%
-7.2%
-4.9%
-5.0%
-6.1%
-4.9%
3.6%
-3.8%
-2.3%
-2.0%

BrightSpring Health Services, Inc. · BTSG

1.6%
1.5%
2.6%
3.0%
0.8%
0.5%
2.3%
3.5%
-1.2%
1.6%
-0.3%
0.9%
0.6%
1.3%
1.2%
1.1%
1.9%
2.4%
2.7%

Doximity, Inc. · DOCS

6.5%
7.4%
5.4%
2.6%
3.8%
4.3%
3.5%
3.0%
3.7%
6.3%
4.3%
4.7%
5.6%
8.2%
4.8%
5.5%
6.1%
7.0%
2.4%

HealthEquity, Inc. · HQY

0.0%
-1.0%
-0.2%
-0.1%
0.2%
0.4%
0.8%
0.8%
1.0%
1.3%
1.4%
1.9%
0.6%
1.3%
2.6%
2.7%
2.4%
2.2%
3.2%

HeartFlow, Inc. · HTFL

0.0%
0.0%
-13%
-14%
-25%
-22%
-7.3%
-8.8%
-13%

Hinge Health, Inc. · HNGE

-5.1%
-7.0%
-0.9%
9.7%
5.9%
-306%
-1.5%
6.8%
8.4%

Omnicell, Inc. · OMCL

1.8%
0.9%
0.4%
0.7%
1.1%
-2.5%
-1.5%
0.4%
0.2%
-1.3%
-1.2%
0.2%
0.4%
0.7%
-0.7%
0.5%
0.6%
0.0%
1.1%

Privia Health Group, Inc. · PRVA

-4.1%
-5.7%
-3.3%
-1.2%
-1.0%
0.4%
1.3%
1.3%
1.0%
0.2%
0.1%
0.8%
0.9%
0.8%
0.8%
0.5%
2.0%
1.5%
1.0%

Teladoc Health, Inc. · TDOC

-0.6%
0.1%
-48%
-25%
-0.6%
-35%
-1.0%
-1.2%
-1.1%
-0.9%
-2.2%
-26%
-1.4%
-1.5%
-3.8%
-2.1%
-2.0%
-1.4%
-2.5%

Tempus AI, Inc. · TEM

-12%
-10%
-30%
-26%
-13%
-13%
-11%
-13%
-41%
-156%
-11%
-11%
-9.4%
-6.5%
-4.6%
-4.8%
-5.6%

Veeva Systems Inc. · VEEV

5.3%
4.5%
4.5%
3.4%
3.8%
3.2%
1.7%
2.8%
3.2%
3.2%
3.5%
3.5%
6.0%
-2.9%
4.1%
3.3%
5.7%
-2.3%
4.0%

Waystar Holding Corp. · WAY

0.3%
0.3%
0.5%
0.6%
1.5%
1.6%
0.7%
0.8%
0.8%
0.2%
0.6%
1.2%
1.5%
1.4%
1.3%
1.2%
1.6%

ROCE change · reported quarter history

Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.

10x Genomics, Inc. · TXG

−2.7 pp
−0.8 pp
−0.9 pp
+0.1 pp
−6.6 pp
−3.8 pp
−1.5 pp
+2.2 pp
+6.1 pp
+0.3 pp
+2.3 pp
+8.5 pp
+1.2 pp
+3.8 pp
+2.9 pp

BrightSpring Health Services, Inc. · BTSG

−0.8 pp
−1.0 pp
−0.3 pp
+0.5 pp
−2.0 pp
+1.1 pp
−2.6 pp
−2.6 pp
+1.8 pp
−0.3 pp
+1.5 pp
+0.2 pp
+1.3 pp
+1.1 pp
+1.5 pp

Doximity, Inc. · DOCS

−2.7 pp
−3.1 pp
−1.9 pp
+0.4 pp
−0.1 pp
+2.0 pp
+0.8 pp
+1.7 pp
+1.9 pp
+1.9 pp
+0.5 pp
+0.8 pp
+0.5 pp
−1.2 pp
−2.4 pp

HealthEquity, Inc. · HQY

+0.2 pp
+1.4 pp
+1.0 pp
+0.9 pp
+0.8 pp
+0.9 pp
+0.6 pp
+1.1 pp
−0.4 pp
0.0 pp
+1.2 pp
+0.8 pp
+1.8 pp
+0.9 pp
+0.6 pp

HeartFlow, Inc. · HTFL

−12.6 pp
−13.5 pp
+5.3 pp
+4.7 pp
+11.6 pp

Hinge Health, Inc. · HNGE

+4.2 pp
+16.7 pp
−0.6 pp
−2.9 pp
+2.5 pp

Omnicell, Inc. · OMCL

−0.7 pp
−3.4 pp
−1.9 pp
−0.3 pp
−0.9 pp
+1.2 pp
+0.3 pp
−0.2 pp
+0.2 pp
+2.0 pp
+0.5 pp
+0.3 pp
+0.2 pp
−0.7 pp
+1.8 pp

Privia Health Group, Inc. · PRVA

+3.1 pp
+6.1 pp
+4.6 pp
+2.5 pp
+2.0 pp
−0.2 pp
−1.2 pp
−0.5 pp
−0.1 pp
+0.6 pp
+0.7 pp
−0.3 pp
+1.1 pp
+0.7 pp
+0.2 pp

Teladoc Health, Inc. · TDOC

0.0 pp
−35.1 pp
+46.5 pp
+23.5 pp
−0.5 pp
+34.1 pp
−1.2 pp
−24.6 pp
−0.3 pp
−0.6 pp
−1.6 pp
+23.7 pp
−0.6 pp
+0.1 pp
+1.3 pp

Tempus AI, Inc. · TEM

−1.5 pp
−3.1 pp
+2.1 pp
+0.1 pp
+0.7 pp
+2.8 pp
+31.6 pp
+149.7 pp
+5.9 pp
+5.7 pp
+3.8 pp

Veeva Systems Inc. · VEEV

−1.5 pp
−1.3 pp
−2.8 pp
−0.6 pp
−0.6 pp
0.0 pp
+1.8 pp
+0.7 pp
+2.8 pp
−6.1 pp
+0.6 pp
−0.2 pp
−0.3 pp
+0.6 pp
−0.1 pp

Waystar Holding Corp. · WAY

+0.2 pp
+0.3 pp
+0.2 pp
+0.2 pp
−0.7 pp
−1.4 pp
−0.1 pp
+0.4 pp
+0.7 pp
+1.2 pp
+0.7 pp
0.0 pp
+0.1 pp
07 · compare level, then change

Valuation Against Growth & Quality

Veeva Systems Inc. has the lowest Guarded PEG among the 29 Health Information Services companies compared here, at 1.47×. HealthEquity, Inc. is next at 1.57×. Spok Holdings, Inc. has the lowest P/E at 18.2×, so level and change sit with different companies. 6 of 29 companies report a comparable reading, the latest through Jun 2026.

What the numbers say: Veeva Systems Inc. has the lowest comparable Guarded PEG at 1.47×, 6.4% below HealthEquity, Inc.. Only 6 of 29 companies pass the guard, so no broad “cheapest stock” conclusion is defensible unless the current multiple, own-history position and growth durability agree.

LeaderVeeva Systems Inc. · 1.47×
Gap6.4% versus #2 · HealthEquity, Inc.
Persistence0/8 recent comparable periods
Coverage6/29 companies · 39 observations

Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.

This conclusion weakens if: The next two comparable reports reverse the current p/e signal.

PEG is shown only when earnings are positive and three-year EPS growth is between 5% and 60%. It is recomputed consistently as the trailing P/E divided by that growth rate — reported earnings, never an expected-earnings multiple. On Indian companies it is shown only where the two data sources reconciled. A missing PEG is more honest than a low-base fiction.
Guarded PEGlowest PEG
1Veeva Systems Inc. VEEV1.5
2HealthEquity, Inc. HQY1.6
3Doximity, Inc. DOCS1.8
4Spok Holdings, Inc. SPOK2.3
5Privia Health Group, Inc. PRVA3.9
P/Elowest P/E
1Spok Holdings, Inc. SPOK18.2
2Doximity, Inc. DOCS23.8
3Veeva Systems Inc. VEEV27.8
4HealthEquity, Inc. HQY30.7
5HealthStream, Inc. HSTM30.9
Valuation · company comparison
6/29 level · 18/29 change

Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.

All-company data · latest reported quarter

Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.

CompanyGuarded PEGP/EReported
HealthStream, Inc. HSTM4.930.9Mar 2026
Privia Health Group, Inc. PRVA3.9128.6Mar 2026
Spok Holdings, Inc. SPOK2.318.2Mar 2026
Doximity, Inc. DOCS1.823.8Mar 2026
HealthEquity, Inc. HQY1.630.7Jun 2026
Veeva Systems Inc. VEEV1.527.8Jun 2026
BrightSpring Health Services, Inc. BTSG34.6Mar 2026
Waystar Holding Corp. WAY36.0Mar 2026
Omnicell, Inc. OMCL75.9Mar 2026
Certara, Inc. CERT174.6Mar 2026
Schrödinger, Inc. SDGR66.3Mar 2026
GoodRx Holdings, Inc. GDRX32.7Mar 2026
Talkspace, Inc. TALK517.5Mar 2026
Phreesia, Inc. PHR61.4Jun 2026
NRC Health NRC43.5Mar 2026
TruBridge, Inc. TBRG73.2Mar 2026
Simulations Plus, Inc. SLP42.8Jun 2026
LifeMD, Inc. LFMD72.2Mar 2026
Full 20-quarter history · every available company

Guarded PEG · reported quarter history

Doximity, Inc. · DOCS

2.1
1.0
0.8
1.0
1.0
1.0
1.1
1.3
1.8

HealthEquity, Inc. · HQY

1.3
1.6

HealthStream, Inc. · HSTM

1.2
1.9
0.9
1.2
0.9
1.5
5.9
3.1
4.9

Privia Health Group, Inc. · PRVA

3.6
6.4
2.4
3.9

Spok Holdings, Inc. · SPOK

2.7
2.3

Veeva Systems Inc. · VEEV

2.2
1.7
1.3
9.2
9.9
4.0
3.2
1.6
1.3
2.0
2.1
1.5
1.5

P/E · reported quarter history

Showing the 12 largest of 18 companies with a series here. The remaining 6 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.

BrightSpring Health Services, Inc. · BTSG

139.2
181.5
68.7
43.1
34.6

Certara, Inc. · CERT

178.6
267.9
151.8
234.0
174.6

Doximity, Inc. · DOCS

172.1
85.0
74.4
49.7
46.5
61.0
61.1
61.9
36.6
42.5
37.4
35.0
50.1
53.4
52.3
52.4
58.1
36.9
23.8

GoodRx Holdings, Inc. · GDRX

184.0
140.8
116.3
55.1
49.8
47.0
30.1
32.7

HealthEquity, Inc. · HQY

452.9
210.8
118.1
85.8
65.4
78.2
101.3
62.6
58.8
43.4
34.8
30.7

HealthStream, Inc. · HSTM

124.3
146.4
94.9
94.4
70.9
63.7
69.5
58.5
50.2
54.1
46.0
47.3
44.4
48.2
51.1
41.3
41.5
37.8
30.9

Omnicell, Inc. · OMCL

86.8
111.4
86.9
90.3
85.3
420.2
164.9
76.0
58.8
70.8
1,132.5
75.9

Privia Health Group, Inc. · PRVA

251.0
96.7
74.2
121.2
130.6
144.8
182.1
177.7
187.1
209.1
191.5
131.7
128.6

Schrödinger, Inc. · SDGR

202.5
58.1
50.5
66.3

Talkspace, Inc. · TALK

309.0
128.0
139.0
92.0
90.8
517.5

Veeva Systems Inc. · VEEV

118.7
89.9
71.6
92.0
68.6
56.9
56.0
61.5
55.4
64.4
58.6
51.2
51.6
54.0
49.5
58.4
56.7
37.5
27.8

Waystar Holding Corp. · WAY

415.1
85.2
61.2
53.7
36.0
08 · compare level, then change

Enterprise Value & Book Value

SOPHiA GENETICS SA has the lowest EV/EBITDA among the 29 Health Information Services companies compared here, at 0.36×. Claritev Corporation is next at 0.58×. Teladoc Health, Inc. has the lowest P/BV at 0.06×, so level and change sit with different companies. 23 of 29 companies report a comparable reading, the latest through Mar 2026.

What the numbers say: SOPHiA GENETICS SA leads ev/ebitda at 0.36×; Teladoc Health, Inc. leads p/bv at 0.06×.

LeaderSOPHiA GENETICS SA · 0.36×
Gap37.9% versus #2 · Claritev Corporation
Persistence0/8 recent comparable periods
Coverage23/29 companies · 279 observations

Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.

This conclusion weakens if: The next two comparable reports reverse the current p/bv signal.

EV/EBITDA includes debt in enterprise value and is useful across different capital structures. P/BV prices the company against its own book. Both are market multiples on reported figures, not intrinsic-value estimates and not forecasts.
EV/EBITDAlowest EV/EBITDA
1SOPHiA GENETICS SA SOPH0.4
2Claritev Corporation CTEV0.6
3GoodRx Holdings, Inc. GDRX5.9
4Teladoc Health, Inc. TDOC7.2
5HealthStream, Inc. HSTM8.2
P/BVlowest P/BV
1Teladoc Health, Inc. TDOC0.1
2Evolent Health, Inc. EVH0.7
3Certara, Inc. CERT0.9
4GoodRx Holdings, Inc. GDRX1.1
5Waystar Holding Corp. WAY1.2
Enterprise and book valuation · company comparison
23/29 level · 28/29 change

Solid lines show level; dotted lines show change when “Both” is selected. Missing reports break the line rather than being invented.

All-company data · latest reported quarter

Each figure is the company’s latest single reported quarter. The rankings above use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.

CompanyEV/EBITDAP/BVReported
Talkspace, Inc. TALK914.37.7Mar 2026
10x Genomics, Inc. TXG316.33.4Mar 2026
LifeMD, Inc. LFMD313.311.4Mar 2026
Hinge Health, Inc. HNGE97.326.7Mar 2026
Privia Health Group, Inc. PRVA46.73.4Mar 2026
Veeva Systems Inc. VEEV25.23.5Jun 2026
Evolent Health, Inc. EVH23.70.7Mar 2026
BrightSpring Health Services, Inc. BTSG19.14.2Mar 2026
Simulations Plus, Inc. SLP17.32.5Jun 2026
NRC Health NRC16.528.4Mar 2026
Doximity, Inc. DOCS15.44.5Mar 2026
HealthEquity, Inc. HQY15.33.4Jun 2026
Waystar Holding Corp. WAY14.41.2Mar 2026
Phreesia, Inc. PHR13.51.6Jun 2026
Omnicell, Inc. OMCL13.21.2Mar 2026
Certara, Inc. CERT12.10.9Mar 2026
Spok Holdings, Inc. SPOK11.01.6Mar 2026
TruBridge, Inc. TBRG8.21.2Mar 2026
HealthStream, Inc. HSTM8.21.7Mar 2026
Teladoc Health, Inc. TDOC7.20.1Mar 2026
GoodRx Holdings, Inc. GDRX5.91.1Mar 2026
Claritev Corporation CTEV0.6-1.2Mar 2026
SOPHiA GENETICS SA SOPH0.47.8Mar 2026
Tempus AI, Inc. TEM19.5Mar 2026
HeartFlow, Inc. HTFL7.3Mar 2026
Omada Health, Inc. OMDA3.2Mar 2026
Schrödinger, Inc. SDGR2.7Mar 2026
Weave Communications, Inc. WEAV4.4Mar 2026
Carlsmed, Inc. CARL2.7Mar 2026
Full 20-quarter history · every available company

EV/EBITDA · reported quarter history

Showing the 12 largest of 23 companies with a series here. The remaining 11 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.

10x Genomics, Inc. · TXG

316.3

BrightSpring Health Services, Inc. · BTSG

16.7
20.2
17.1
18.2
15.7
18.3
18.7
21.4
19.1

Certara, Inc. · CERT

94.0
67.0
60.5
59.0
25.4
27.6
68.5
30.8
70.3
50.9
8,623.8
22.3
240.2
20.6
20.7
15.7
12.1

Doximity, Inc. · DOCS

151.1
77.5
77.8
51.2
40.6
44.1
40.3
40.1
22.6
27.4
24.5
23.4
35.0
39.7
42.2
43.2
49.9
29.7
15.4

GoodRx Holdings, Inc. · GDRX

268.1
95.4
29.1
29.8
32.4
47.7
28.1
29.7
33.2
36.5
39.1
22.4
13.9
11.7
12.3
10.5
7.0
5.9

HealthEquity, Inc. · HQY

45.3
46.6
55.9
49.8
57.6
34.6
26.4
28.7
27.3
26.0
26.3
23.4
25.7
31.9
22.5
23.3
19.7
16.7
15.3

Hinge Health, Inc. · HNGE

97.3

Omnicell, Inc. · OMCL

38.9
50.2
40.0
38.7
31.9
29.9
50.7
66.9
58.2
35.3
27.2
27.5
42.3
25.0
17.8
14.1
14.4
24.3
13.2

Privia Health Group, Inc. · PRVA

745.4
167.5
89.1
87.8
93.1
87.1
89.2
79.0
80.5
89.8
71.8
57.0
46.7

Teladoc Health, Inc. · TDOC

131.7
226.5
152.3
40.4
25.8
13.1
11.0
18.7
17.9
13.2
7.2

Veeva Systems Inc. · VEEV

90.7
64.1
47.7
62.5
46.5
49.1
59.5
68.0
62.4
63.8
49.2
42.2
36.1
45.0
54.2
64.9
60.7
28.2
25.2

Waystar Holding Corp. · WAY

16.9
19.7
23.8
22.7
21.4
19.6
19.7
14.4

P/BV · reported quarter history

Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.

10x Genomics, Inc. · TXG

20.3
20.4
10.7
6.6
4.2
5.2
8.1
8.3
6.5
9.0
6.3
3.2
3.8
2.5
1.5
1.8
1.9
2.6
3.4

BrightSpring Health Services, Inc. · BTSG

1.2
1.2
1.6
1.8
1.9
2.4
2.9
3.8
4.2

Doximity, Inc. · DOCS

19.5
11.4
11.4
7.5
6.6
7.0
6.5
6.7
4.6
6.0
5.6
5.7
8.5
9.7
10.1
11.2
12.6
8.4
4.5

HealthEquity, Inc. · HQY

3.0
2.4
2.8
2.6
3.5
2.7
2.4
3.0
3.1
3.2
3.3
3.2
3.5
4.5
3.5
3.9
3.8
3.5
3.4

HeartFlow, Inc. · HTFL

11.0
8.3
7.3

Hinge Health, Inc. · HNGE

23.3
18.6
20.6
26.7

Omnicell, Inc. · OMCL

5.9
7.0
5.3
4.6
3.4
2.0
2.3
2.9
1.7
1.4
1.1
1.0
1.6
1.7
1.3
1.1
1.1
1.7
1.2

Privia Health Group, Inc. · PRVA

6.1
6.5
6.7
7.2
8.2
5.2
6.2
5.8
5.0
4.9
4.0
3.5
3.6
3.7
4.1
4.1
4.3
4.0
3.4

Teladoc Health, Inc. · TDOC

1.3
0.9
1.3
0.9
0.7
1.7
1.9
1.8
1.3
1.5
1.1
1.1
1.1
1.1
1.0
1.1
1.0
0.9
0.1

Tempus AI, Inc. · TEM

55.0
97.2
25.6
35.6
28.3
21.4
19.5

Veeva Systems Inc. · VEEV

17.6
12.5
9.2
10.7
7.7
7.3
7.3
7.9
7.1
7.2
6.6
6.0
6.2
6.5
6.1
7.0
6.8
4.6
3.5

Waystar Holding Corp. · WAY

1.2
1.6
2.1
2.1
2.2
2.1
1.6
1.2
09 · let price answer last

Market action

BrightSpring Health Services, Inc. has the strongest one-year price move in Health Information Services at +268.9%. 10x Genomics, Inc. leads on Mansfield relative strength against the S&P 500 at +106.6%. 14 of 28 covered companies are above zero on that measure. Every line covers 314 weekly closes through 2026-07-28.

Every price line is indexed to 100 over the chosen window. Mansfield relative strength compares a price ratio with its own 52-week average; zero separates leadership from lagging.
Price and relative strength

Price is rebased to 100 inside the selected window. Pair ratio rebases each selected company against one chosen denominator.

Before the conclusion · check the blind spots

What can make this comparison misleading?

This Health Information Services comparison names 4 specific ways its own evidence can mislead, all listed below. All 29 companies here report on comparable dates, so no rank carries a stale marker. A high growth rate can still be a low-base artefact.

Keep these limits visible

  • A high growth rate can be a low-base artefact. The page keeps level and change separate for that reason.
  • A high ROCE can be temporary or flattered by a small capital base. Read it beside margin, cash conversion and reinvestment.
  • The 4-Factor Sector Score ranks research priority, not portfolio action. Management quality, catalysts and risks need equally fresh evidence before capital is deployed.
  • An “all companies” line chart preserves completeness, but rank changes should be checked against reporting dates before drawing a conclusion.
10 · the complete set

Which companies are included?

All 29 companies in the canonical Health Information Services membership are listed below, largest market value first — nothing is silently dropped, even where a company reports too little to rank. The charts above default to a selective view; this register is the complete set, with each company's own latest reporting date beside it.

AHEAD means the company is beating the index by 5% or more over three months. LAGGING, FUNDAMENTALS UP means it is 20% or more behind over a year while its trailing twelve-month earnings grew 20% or more. Both rules are fixed and applied the same way in every sector.

CompanyMarket valuePricePriced toLatest fundamentals
Veeva Systems Inc. VEEVAHEAD$32.7B$2012026-07-28Jun 2026
BrightSpring Health Services, Inc. BTSGAHEAD26/26 WEEKS$15.1B$72.52026-07-28Mar 2026
HealthEquity, Inc. HQYAHEAD$8.5B$1012026-07-28Jun 2026
Tempus AI, Inc. TEM$7.7B$42.92026-07-28Mar 2026
10x Genomics, Inc. TXGAHEAD24/26 WEEKS$6.0B$47.12026-07-28Mar 2026
Hinge Health, Inc. HNGEAHEAD$5.8B$75.32026-07-28Mar 2026
Waystar Holding Corp. WAYAHEADLAGGING, FUNDAMENTALS UP$4.5B$23.72026-07-28Mar 2026
Doximity, Inc. DOCS$3.9B$21.42026-07-28Mar 2026
Privia Health Group, Inc. PRVA$3.1B$24.82026-07-28Mar 2026
HeartFlow, Inc. HTFL$2.2B$25.62026-07-28Mar 2026
Omnicell, Inc. OMCL$2.0B$43.12026-07-28Mar 2026
Teladoc Health, Inc. TDOCAHEAD$1.7B$9.42026-07-28Mar 2026
Certara, Inc. CERTAHEAD$1.2B$7.92026-07-28Mar 2026
Omada Health, Inc. OMDAAHEAD$1.2B$20.42026-07-28Mar 2026
Schrödinger, Inc. SDGRAHEAD$1.1B$15.32026-07-28Mar 2026
GoodRx Holdings, Inc. GDRXAHEAD$1.1B$3.12026-07-28Mar 2026
Talkspace, Inc. TALK$873M$5.22026-07-28Mar 2026
HealthStream, Inc. HSTMAHEAD$843M$28.92026-07-28Mar 2026
Phreesia, Inc. PHRAHEAD$671M$10.92026-07-28Jun 2026
Weave Communications, Inc. WEAVAHEAD$548M$6.92026-07-28Mar 2026
NRC Health NRCAHEAD$503M$22.32026-07-28Mar 2026
SOPHiA GENETICS SA SOPH$467M$5.62026-07-28Mar 2026
Evolent Health, Inc. EVH$421M$3.72026-07-28Mar 2026
TruBridge, Inc. TBRG$388M$26.22026-07-10Mar 2026
Claritev Corporation CTEV$386M$22.72026-07-28Mar 2026
Simulations Plus, Inc. SLPAHEAD$371M$18.32026-07-28Jun 2026
Carlsmed, Inc. CARLAHEAD$335M$12.32026-07-28Mar 2026
Spok Holdings, Inc. SPOK$228M$10.92026-07-28Mar 2026
LifeMD, Inc. LFMD$186M$3.82026-07-28Mar 2026
Evidence and freshness

How was this comparison built?

This comparison is built from the reported filings of 29 Health Information Services companies, normalized to a common $ scale and a shared quarter axis of up to 20 quarters each. Fundamentals run through Jun 2026 and market data through 2026-07-28. A second data feed fills gaps only after identity and scale reconciliation, and missing observations are never interpolated.

FundamentalsThrough Jun 2026 · up to 20 quarters per company
Market dataThrough 2026-07-28 · weekly price and relative-strength history
Derived metricsGrowth, changes, CAPEX intensity, net debt, guarded PEG and P/BV÷ROE are calculated only when their inputs are comparable.
Score confidenceMissing and stale evidence reduces confidence and pulls the 0–100 research-priority score toward neutral.
Questions investors ask · short, speakable answers

Health Information Services company comparison FAQs

These 18 answers restate the Health Information Services comparison above in question form. Every one is computed from the same 29 companies and the same reported filings as the rankings and charts, current through Jun 2026. Price and relative-strength answers run through 2026-07-28. Nothing here is estimated, and none of it is a recommendation.

Which Health Information Services company is the biggest?

BrightSpring Health Services, Inc. is the largest, with trailing-twelve-month revenue of $13,647 million, ahead of Veeva Systems Inc. at $3,319 million. That covers 28 of 29 companies with comparable reporting through Mar 2026.

Which Health Information Services company is growing fastest?

Carlsmed, Inc. has the fastest revenue growth at 75% year on year, across 28 of 29 comparable companies. Fast growth off a small base is not the same as proven scale — check whether the rate holds across several quarters on the chart above before treating it as a trend.

Which Health Information Services company has the best profit margins?

Veeva Systems Inc. has the highest operating margin at 30.9%, from 29 of 29 comparable companies. 10x Genomics, Inc. shows the biggest recent improvement, at +14.1 percentage points. A high margin matters most when it is holding or rising, not when it is peaking.

Which Health Information Services company makes the most profit?

Veeva Systems Inc. earns the most, at $941 million of trailing-twelve-month net profit, from 28 of 29 comparable companies. Waystar Holding Corp. has the fastest profit growth at 100%, though growth off a small or recovering profit base overstates how much has actually changed.

Which Health Information Services company earns the highest return on capital?

Hinge Health, Inc. leads on return on capital employed at 8.4%, across 29 of 29 companies. Read it beside the length of its reported history: a high return that repeats for years is evidence of a durable business, while a single high reading can be a small capital base or one good year.

Which Health Information Services stock is the cheapest?

On guarded PEG — where a LOWER number is cheaper — Veeva Systems Inc. screens cheapest at 1.47×. Only 6 of 29 companies pass the comparability guard, so this is not a sector-wide "cheapest stock" verdict. Cheap on a multiple is a reason to investigate, never a reason to buy on its own.

Which Health Information Services company has the strongest balance sheet?

Omada Health, Inc. carries the lowest comparable gross debt at $0 million, from 29 of 29 companies. Absolute rupee debt alone does not settle it, because company scale differs — net debt and debt-to-equity in the chart above carry more information, and a very low-debt balance sheet can also mean under-investment.

Which Health Information Services company is investing most in new capacity?

Claritev Corporation reports the largest capital spending at $47 million, across 28 of 29 companies. Spending consumes cash before it earns anything, so treat the ranking as a diligence queue: check commissioning, utilisation and the return earned on the completed assets before reading spend as value creation.

Is the Health Information Services sector beating the market?

Health Information Services has underperformed S&P 500 by 4.4% over the last 52 weeks and 13.7% over 13 weeks, measured on an equal-weight index of its current members. Inside the sector, 14 of 28 covered companies are beating the market on their own. Sector strength does not transfer evenly to every stock in it.

Which Health Information Services stock has the strongest price momentum?

10x Genomics, Inc. has the strongest relative strength against S&P 500. Relative strength answers last, after growth, quality and valuation: price can move well before the fundamentals confirm it, and sometimes without them confirming at all.

Which Health Information Services company scores highest for research priority?

Simulations Plus, Inc. scores 65.9 out of 100 with 52.7% evidence confidence, from 24.6 points on growth and earnings, 17.8 on capital efficiency, 10.1 on valuation and 13.4 on relative strength. This ranks what deserves work next. It is not a buy recommendation, and management quality, catalysts and risk still need separate research.

How many Health Information Services companies does this comparison cover, and over what period?

It compares 29 listed companies over up to 20 reported quarters of fundamentals and 5 fiscal years of capital allocation, ending Jun 2026, plus weekly price and relative-strength history. Membership is the full sector list — nothing is dropped for having thin data.

What is the total market cap of the Health Information Services sector?

The 29 Health Information Services companies on this page carry $104,011 million of combined market value. Veeva Systems Inc. is the largest at $32,684 million, about 31% of the sector's total on its own. Market value moves with price, so this reading is dated 2026-07-28.

What is the Health Information Services sector's P/E ratio?

The median price-to-earnings ratio across the 29 Health Information Services companies on this page is 43.5×, measured on the 18 that report a comparable figure. A sector-level history for this multiple is not held here, so this is a cross-section of today, not a comparison with the sector’s own past. Figures are as of 2026-07-28.

How is the Health Information Services sector performing?

14 of the 28 covered Health Information Services companies are beating S&P 500 on Mansfield relative strength. The sector itself is 4.4% behind S&P 500 over 52 weeks on an equal-weight index of its current members. Readings are as of 2026-07-28.

How many Health Information Services stocks are listed in the US?

This comparison covers 29 listed Health Information Services companies in the US, each above the size floor the site applies. The full ranked list is on this page, with reported fundamentals through Jun 2026. Membership is the full industry list — nothing is dropped for having thin data.

Why are some values on this page blank?

A blank means that company did not report a comparable figure for that period, so nothing is shown. Missing observations are never interpolated, carried forward, or replaced with a similar-looking accounting line, and a company with missing evidence has its research score pulled toward neutral rather than being scored as bad.

Is this investment advice?

No. Every figure here is a deterministic calculation from reported company filings and market data, published for research. It contains no recommendation to buy or sell any security, does not account for your circumstances, and is not a substitute for advice from a licensed adviser.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI